{"content":"<li class=\"n-box-item date-title\" data-end=\"1529639999\" data-start=\"1529553600\" data-txt=\"Monday, December 23, 2019\">Thursday, June 21, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3365723\" data-ts=\"1529624370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGLB\" target=\"_blank\">SGLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365723-sigma-labsminus-7_2-amid-proposed-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sigma Labs -7.2% amid proposed offering</a></h4><ul>   <li>Quality assurance software maker Sigma Labs (NASDAQ:<a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a>) is <font color='red'>off 7.2%</font> in postmarket trading after announcing a <a href=\"https://seekingalpha.com/pr/17199134-sigma-labs-announces-proposed-public-offering-securities\" target=\"_blank\">proposed public offering</a> of common stock, warrants and convertible preferred shares.</li>    <li>Terms of the offering aren't set yet.</li>    <li>Preferred stock would be offered in lieu of common shares to any investor where the result would be beneficial ownership over 4.99%.</li>    <li>Dawson James Securities is exclusive placement agent.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365723\" data-linked=\"Sigma Labs -7.2% amid proposed offering\" data-tweet=\"$SGLB - Sigma Labs -7.2% amid proposed offering https://seekingalpha.com/news/3365723-sigma-labsminus-7_2-amid-proposed-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3365723-sigma-labsminus-7_2-amid-proposed-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365721\" data-ts=\"1529623349\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCS\" target=\"_blank\">TCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365721-container-store-dips-on-holders-filing-to-sell-up-to-32_49m-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Container Store dips on holder&#39;s filing to sell up to 32.49M shares</a></h4><ul>   <li>The Container Store Group (NYSE:<a href='https://seekingalpha.com/symbol/TCS' title='The Container Store Group, Inc.'>TCS</a>) is <font color='red'>3.1% lower</font> in light aftermarket trading after an <a href=\"https://seekingalpha.com/filing/4075319\" target=\"_blank\">S-3 filing</a> from a holder expecting to offer up to 32,492,421 shares.</li>    <li>That's at a maximum offer price/share of $8.71, or aggregate price of just over $283M. Shares closed at that price today, and are quoting at $8.44 postmarket.</li>    <li>The Container Store won't receive any proceeds.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365721\" data-linked=\"Container Store dips on holder&#39;s filing to sell up to 32.49M shares\" data-tweet=\"$TCS - Container Store dips on holder&#39;s filing to sell up to 32.49M shares https://seekingalpha.com/news/3365721-container-store-dips-on-holders-filing-to-sell-up-to-32_49m-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3365721-container-store-dips-on-holders-filing-to-sell-up-to-32_49m-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365709\" data-ts=\"1529616950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365709-after-hours-gainers-losers-06-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (06/21/2018)</a></h4><ul>     <li><b>Top gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>&nbsp;<font color='green'>+5.7%</font>. <a href='https://seekingalpha.com/symbol/TEO' title='Telecom Argentina S.A.'>TEO</a>&nbsp;<font color='green'>+4.4%</font>. <a href='https://seekingalpha.com/symbol/CRCM' title='Care.com, Inc.'>CRCM</a> <font color='green'>+3.2%</font>. <a href='https://seekingalpha.com/symbol/CX' title='Cemex, S.A.B. de C.V.'>CX</a>&nbsp;<font color='green'>+2.5%</font>. AOI <font color='green'>+2.1%</font>.</li>     <li><strong>Top Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a> <font color='red'>-10.8%</font>. NWY&nbsp;<font color='red'>-3.4%</font>.&nbsp;&nbsp;<a href='https://seekingalpha.com/symbol/TLRA' title='Telaria, Inc.'>TLRA</a>&nbsp;<font color='red'>-1.8%.&nbsp;</font><a href='https://seekingalpha.com/symbol/SPLK' title='Splunk Inc.'>SPLK</a>&nbsp;<font color='red'>-1.7%</font>. <a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>&nbsp;<font color='red'>-1.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365709\" data-linked=\"After Hours Gainers / Losers (06/21/2018)\" data-tweet=\"$TNDM $TNDM $TEO - After Hours Gainers / Losers (06/21/2018) https://seekingalpha.com/news/3365709-after-hours-gainers-losers-06-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3365709-after-hours-gainers-losers-06-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365695\" data-ts=\"1529614624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMCX\" target=\"_blank\">AMCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365695-amc-networksminus-3_6-bernstein-cuts-to-underperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMC Networks -3.6% as Bernstein cuts to Underperform</a></h4><ul>    <li>AMC Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/AMCX' title='AMC Networks Inc.'>AMCX</a>) <font color='red'>fell 3.6%</font> today, pulling back from the edge of a 52-week high hit last Friday, after a cut to Underperform at Bernstein -- which is fading the likelihood the network will get acquired at a premium.</li>    <li>There's no motivated buyers for AMC (or other \"free radicals\" like Discovery (NASDAQ:<a href='https://seekingalpha.com/symbol/DISCA' title='Discovery Inc A'>DISCA</a>) and Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a>)), analyst Todd Juenger says, highlighting the difference between them and recent targets like Time Warner and Fox.</li>    <li>Figuring an 80/20 chance against an acquisition (and estimations of stand-alone value of $53/share vs. takeout of $82), he expects the price target is $59, about 9.3% downside from today's close. (h/t Bloomberg)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365695\" data-linked=\"AMC Networks -3.6% as Bernstein cuts to Underperform\" data-tweet=\"$AMCX $AMCX $DISCA - AMC Networks -3.6% as Bernstein cuts to Underperform https://seekingalpha.com/news/3365695-amc-networksminus-3_6-bernstein-cuts-to-underperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3365695-amc-networksminus-3_6-bernstein-cuts-to-underperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365694\" data-ts=\"1529614447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLAB\" target=\"_blank\">SLAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365694-loop-capital-initiates-silicon-labs-10-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Loop Capital initiates Silicon Labs at 10% upside</a></h4><ul><li>        Loop Capital <a href=\"https://www.streetinsider.com/New+Coverage/Loop+Capital+Starts+Silicon+Labs+%28SLAB%29+at+Hold/14331878.html\" target=\"_blank\">starts</a> Silicon Labs (NASDAQ:<a href='https://seekingalpha.com/symbol/SLAB' title='Silicon Laboratories, Inc.'>SLAB</a>) at a Hold rating and $116 price target.</li><li>               The target represents a 10% upside to today&rsquo;s close.&nbsp;</li><li>               Silicon Labs is&nbsp;<font color='green'>up 0.7%</font>&nbsp;aftermarket to $105.84. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3365694\" data-linked=\"Loop Capital initiates Silicon Labs at 10% upside\" data-tweet=\"$SLAB - Loop Capital initiates Silicon Labs at 10% upside https://seekingalpha.com/news/3365694-loop-capital-initiates-silicon-labs-10-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3365694-loop-capital-initiates-silicon-labs-10-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365692\" data-ts=\"1529613935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEGA\" target=\"_blank\">PEGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365692-pegasystems-increases-share-repurchase-program-to-50m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pegasystems increases share repurchase program to $50M</a></h4><ul><li>        Pegasystems (NASDAQ:<a href='https://seekingalpha.com/symbol/PEGA' title='Pegasystems Inc.'>PEGA</a>) <a href=\"https://seekingalpha.com/pr/17198936-pegasystems-extends-current-share-repurchase-program\" target=\"_blank\">announces</a> its board has authorized an expansion to the current share repurchase program.</li><li>               The amount increases from the $23.5M remaining to $50M.&nbsp;</li><li>               The expansion is effective until June 30, 2019. &nbsp;&nbsp;</li><li>               Pegasystems shares are&nbsp;<font color='green'>up 0.3%</font>&nbsp;aftermarket to $58.26.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3365692\" data-linked=\"Pegasystems increases share repurchase program to $50M\" data-tweet=\"$PEGA - Pegasystems increases share repurchase program to $50M https://seekingalpha.com/news/3365692-pegasystems-increases-share-repurchase-program-to-50m?source=tweet\" data-url=\"https://seekingalpha.com/news/3365692-pegasystems-increases-share-repurchase-program-to-50m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365688\" data-ts=\"1529613444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHT\" target=\"_blank\">RHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365688-red-hatminus-10_8-on-q1-beats-downside-q2-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Red Hat -10.8% on Q1 beats, downside Q2 guidance</a></h4><ul><li>        Red Hat (NYSE:<a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a>)&nbsp;<font color='red'>plunges 10.8%</font>&nbsp;aftermarket on Q1 results that beat EPS and revenue estimates with a 20% Y/Y revenue growth. Downside Q2 guidance has revenue of $822M to $830M (consensus: $854.74M) and EPS of $0.81 (consensus: $0.89).</li><li>               Mixed FY19 guidance has revenue from $3.375B to $3.41B (consensus: $3.45B; was: $3.425B to $3.46B) and EPS from $3.44 to $3.48 (consensus: $3.43; was: $3.38 to $3.41).&nbsp;</li><li>               Key metrics: Application Development-rated and other emerging tech subscription revenue, $189M (+37% Y/Y); operating cash flow, $346M (+34%); deferred revenue balance, $2.4B (+19%); cash and equivalents, $2.5B; capital allocations, $150M share repurchase; total operating expenses, $578.7M.&nbsp;</li><li>                  Earnings call is scheduled for 5 PM with a webcast available <a href=\"https://investors.redhat.com/\" target=\"_blank\">here</a>.    </li><li>               <a href=\"https://seekingalpha.com/pr/17198976-red-hat-reports-first-quarter-results-fiscal-year-2019\" target=\"_blank\">Press release</a>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365674-red-hat-beats-0_03-beats-revenue\" target=\"_blank\">Red Hat beats by $0.03, beats on revenue</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365688\" data-linked=\"Red Hat -10.8% on Q1 beats, downside Q2 guidance\" data-tweet=\"$RHT - Red Hat -10.8% on Q1 beats, downside Q2 guidance https://seekingalpha.com/news/3365688-red-hatminus-10_8-on-q1-beats-downside-q2-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3365688-red-hatminus-10_8-on-q1-beats-downside-q2-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365678\" data-ts=\"1529612497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365678-fda-oks-tandems-t-slim-x2-insulin-pump-hypoglycemia-management-feature-shares-up-1-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Tandem&#39;s t:slim X2 insulin pump with hypoglycemia management feature; shares up 1% after hours</a></h4><ul><li>Tandem Diabetes Care (NASDAQ:<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>) is up&nbsp;<font color='green'>1%</font>&nbsp;after hours on light volume on the heels of the FDA's <a href=\"https://seekingalpha.com/pr/17198946-tandem-diabetes-care-announces-fda-approval-t-slim-x2-insulin-pump-basal-iq-technology\" target=\"_blank\">approval </a>of its t:slim X2 Insulin Pump with Basal-IQ, a predictive low glucose suspend feature aimed at reducing the frequency and duration of hypoglycemic (low blood sugar) events.</li><li>The device is approved for use by diabetics as young as six years.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings'>SENS</a>, <a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a>, <a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a>, <a href='https://seekingalpha.com/symbol/MDT' title='Medtronic plc'>MDT</a>, <a href='https://seekingalpha.com/symbol/PODD' title='Insulet Corporation'>PODD</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3365678\" data-linked=\"FDA OKs Tandem&#39;s t:slim X2 insulin pump with hypoglycemia management feature; shares up 1% after hours\" data-tweet=\"$TNDM $TNDM $SENS - FDA OKs Tandem&#39;s t:slim X2 insulin pump with hypoglycemia management feature; shares up 1% after hours https://seekingalpha.com/news/3365678-fda-oks-tandems-t-slim-x2-insulin-pump-hypoglycemia-management-feature-shares-up-1-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3365678-fda-oks-tandems-t-slim-x2-insulin-pump-hypoglycemia-management-feature-shares-up-1-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365672\" data-ts=\"1529612131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGH\" target=\"_blank\">SGH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365672-smart-global-holdings-reports-q3-beats-upside-revenue-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SMART Global Holdings reports Q3 beats, upside revenue guidance</a></h4><ul><li>SMART Global Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings'>SGH</a>)&nbsp;<font color='green'>gains 0.2%</font>&nbsp;aftermarket on Q3 results that beat EPS and revenue estimates with a 62% Y/Y revenue growth. Q4 guidance has upside revenue of $360M to $380M (consensus: $348.50M) and in-line EPS of $1.62 to $1.71 (consensus: $1.67).</li><li>Earnings call is scheduled for 4:30 PM Eastern with a replay available <a href=\"http://ir.smartgh.com/phoenix.zhtml?c=254539&amp;p=irol-irhome\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17198943-smart-global-holdings-reports-third-quarter-fiscal-2018-financial-results\" target=\"_blank\">Press release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3365664-smart-global-holdings-beats-0_07-beats-revenue\" target=\"_blank\">SMART Global Holdings beats by $0.07, beats on revenue</a> (June 21)</li><li>Post updated to correct guidance.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365672\" data-linked=\"SMART Global Holdings reports Q3 beats, upside revenue guidance\" data-tweet=\"$SGH - SMART Global Holdings reports Q3 beats, upside revenue guidance https://seekingalpha.com/news/3365672-smart-global-holdings-reports-q3-beats-upside-revenue-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3365672-smart-global-holdings-reports-q3-beats-upside-revenue-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365656\" data-ts=\"1529610130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LDOS\" target=\"_blank\">LDOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365656-leidos-harris-drop-on-cancelled-peraton-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leidos, Harris drop on cancelled Peraton contract</a></h4><ul><li>        Leidos (NYSE:<a href='https://seekingalpha.com/symbol/LDOS' title='Leidos Holdings, Inc.'>LDOS</a>) shares&nbsp;<font color='red'>drop 1.2%</font>&nbsp;on a Washington Business Journal<a href=\"https://www.bizjournals.com/washington/news/2018/06/21/578-million-peraton-contract-is.html\" target=\"_blank\"> report</a> that the TSA cancelled a $578M contract with its competitor Peraton.</li><li>           Peraton was spun-out from Harris Corporation (NYSE:<a href='https://seekingalpha.com/symbol/HRS' title='Harris Corporation'>HRS</a>), which is&nbsp;<font color='red'>down 1.6%</font>&nbsp;to $142.85. &nbsp;                  </li></ul><div class=\"tiny-share-widget\" data-id=\"3365656\" data-linked=\"Leidos, Harris drop on cancelled Peraton contract\" data-tweet=\"$LDOS $LDOS $LHX - Leidos, Harris drop on cancelled Peraton contract https://seekingalpha.com/news/3365656-leidos-harris-drop-on-cancelled-peraton-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3365656-leidos-harris-drop-on-cancelled-peraton-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365655\" data-ts=\"1529609559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CENX\" target=\"_blank\">CENX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365655-century-aluminumplus-5-b-riley-starts-buy-alcoa-only-rates-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Century Aluminum +5% as B. Riley starts at Buy; Alcoa only rates Neutral</a></h4><ul>     <li>Century Aluminum (<a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='green'>+5.3%</font>) surges at B. Riley starts coverage with a <a href=\"https://www.barrons.com/articles/alcoa-century-aluminum-buy-one-skip-the-other-1529592082?mod=hp_RTA\" target=\"_blank\">Buy rating</a> and $27 price target, seeing the company helped by expected lower alumina prices; because CENX is not fully vertically integrated, the company has been facing the full brunt of higher prices, says analyst Lucas Pipes.</li>     <li>The firm also likes CENX's large exposure to the U.S., and \"with aluminum prices and Midwest premiums at attractive levels, we believe the company will be able to generate strong free cash flow in the coming years.\"</li>     <li>But Pipes initiates Alcoa (<a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='red'>-1.2%</font>) with a Neutral rating and $47 price target, saying higher alumina prices that have helped the company \"tremendously\" are likely to decline.</li>     <li>Pipes also thinks the market is underestimating how soon Alcoa's pensions could be fully funded, but it is poor timing as investors intently focused on capital returns are keeping valuation in check, a situation he thinks is likely to continue until the pension obligation is funded.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365655\" data-linked=\"Century Aluminum +5% as B. Riley starts at Buy; Alcoa only rates Neutral\" data-tweet=\"$CENX $CENX $AA - Century Aluminum +5% as B. Riley starts at Buy; Alcoa only rates Neutral https://seekingalpha.com/news/3365655-century-aluminumplus-5-b-riley-starts-buy-alcoa-only-rates-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3365655-century-aluminumplus-5-b-riley-starts-buy-alcoa-only-rates-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365651\" data-ts=\"1529609105\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SENS\" target=\"_blank\">SENS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365651-fda-oks-senseonics-eversense-cgm-device-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Senseonics Eversense CGM device; shares up 1%</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17198893-fda-approves-worlds-first-long-term-implantable-continuous-glucose-monitoring-system\" target=\"_blank\">approves </a>Senseonics Holdings' (<a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings'>SENS</a> <font color='green'>+1.2%</font>) <a href=\"https://www.eversensediabetes.com/\" target=\"_blank\">Eversense</a> Continuous Glucose Monitoring &#40;CGM&#41;&nbsp;System. The device features an implantable sensor that lasts up to 90 days.</li><li>Management will host a conference call today at 4:30 pm ET to discuss the approval and market launch plans.</li><li>Related tickers: (<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-2.2%</font>)(<a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a> <font color='red'>-1%</font>)(<a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a> <font color='red'>-0.9%</font>)(<a href='https://seekingalpha.com/symbol/MDT' title='Medtronic plc'>MDT</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/PODD' title='Insulet Corporation'>PODD</a> <font color='red'>-1.9%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365651\" data-linked=\"FDA OKs Senseonics Eversense CGM device; shares up 1%\" data-tweet=\"$SENS $SENS $TNDM - FDA OKs Senseonics Eversense CGM device; shares up 1% https://seekingalpha.com/news/3365651-fda-oks-senseonics-eversense-cgm-device-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3365651-fda-oks-senseonics-eversense-cgm-device-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365648\" data-ts=\"1529608358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365648-fox-gains-again-loop-capital-boosts-target-on-bidding-war\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fox gains again; Loop Capital boosts target on bidding war</a></h4><ul>   <li>Shares in Twenty-First Century Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+2.1%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+1.6%</font>) are continuing their recent run after Loop Capital boosted its price target.</li>    <li>The firm targets FOXA at $51, up from $47, vs. current pricing of $48.84.</li>    <li>It's clear that Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='red'>-1.6%</font>) and Disney (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='red'>-0.8%</font>) are \"all in\" with their bids for Fox's media assets, analyst Alan Gould writes. Comcast will go to the low $40s with a bid, and Disney will top again (likely to $42), he says, thinking Comcast is \"close to its limit.\" (h/t Bloomberg)</li>    <li>Fox is still likely to prefer Disney equity over Comcast equity, he adds, if it comes to that.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365648\" data-linked=\"Fox gains again; Loop Capital boosts target on bidding war\" data-tweet=\"$FOX $FOX $FOXA - Fox gains again; Loop Capital boosts target on bidding war https://seekingalpha.com/news/3365648-fox-gains-again-loop-capital-boosts-target-on-bidding-war?source=tweet\" data-url=\"https://seekingalpha.com/news/3365648-fox-gains-again-loop-capital-boosts-target-on-bidding-war\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365646\" data-ts=\"1529608085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NE\" target=\"_blank\">NE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365646-noble-corp-downgraded-jefferies-offshore-drillers-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble Corp. downgraded at Jefferies as offshore drillers drop</a></h4><ul>     <li>Noble Corp. (<a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color='red'>-4.3%</font>) plunges amid broader losses in the oil and gas sector, as Jefferies <a href=\"https://www.barrons.com/articles/energy-offshore-drillers-in-over-their-heads-1529589581?mod=hp_RTA\" target=\"_blank\">downgrades</a> shares to Hold from Buy with a $5 price target, cut from $5.50, citing \"ample downside risk\" to 2019 estimates that leaves the stock fairly valued after its 18% YTD run.</li>     <li>Oilfield service stocks have been moving higher thanks to rising oil prices, but Jefferies analyst Eduardo Royes sees \"few tangible positives\" in the rig market, as contracting still remains relatively unchanged from the last year's depressed levels and many operators seem content not to ramp up their activity; \"as such, the contracted floater rig count remains range-bound,\"&nbsp;Royes writes.</li>     <li>Among offshore drillers, Royes only sees value in Transocean (<a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='red'>-4.4%</font>), which he maintains with a Buy rating and raises his price target to $15; he rates Diamond Offshore (<a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling Inc.'>DO</a> <font color='red'>-1.8%</font>) at Underperform.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365646\" data-linked=\"Noble Corp. downgraded at Jefferies as offshore drillers drop\" data-tweet=\"$NE $NE $RIG - Noble Corp. downgraded at Jefferies as offshore drillers drop https://seekingalpha.com/news/3365646-noble-corp-downgraded-jefferies-offshore-drillers-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/3365646-noble-corp-downgraded-jefferies-offshore-drillers-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365644\" data-ts=\"1529607798\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XRX\" target=\"_blank\">XRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365644-xerox-lower-after-judges-ruling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xerox lower after judge&#39;s ruling</a></h4><ul><li>Xerox (<a href='https://seekingalpha.com/symbol/XRX' title='Xerox Corporation'>XRX</a> <font color='red'>-2.8%</font>) drops to a session low after a judge in the Fujifilm case doesn't dissolve an injunction blocking the merger between the two companies.</li><li>Shares of XRX hit a 52-week low of $26.42 after the ruling broke.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365644\" data-linked=\"Xerox lower after judge&#39;s ruling\" data-tweet=\"$XRX - Xerox lower after judge&#39;s ruling https://seekingalpha.com/news/3365644-xerox-lower-after-judges-ruling?source=tweet\" data-url=\"https://seekingalpha.com/news/3365644-xerox-lower-after-judges-ruling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365643\" data-ts=\"1529607527\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABIL\" target=\"_blank\">ABIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365643-technology-top-5-gainers-losers-of-2_55-pm-06-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (06/21/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+90%</font>. <a href='https://seekingalpha.com/symbol/AGMH' title='AGM Group Holdings Inc.'>AGMH</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight'>BOXL</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/AVLR' title='Avalara'>AVLR</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/IGLD' title='Internet Gold Golden Lines Ltd.'>IGLD</a> <font color='green'>+12%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/CLPS' title='CLPS, Inc'>CLPS</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/STMP' title='Stamps.com Inc.'>STMP</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/BILI' title='Bilibili'>BILI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ACMR' title='ACM Research, Inc.'>ACMR</a> <font color='red'>-10%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3365643\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (06/21/2018)\" data-tweet=\"$ABIL $ABIL $AGMH - Technology - Top 5 Gainers / Losers as of 2.55 PM (06/21/2018) https://seekingalpha.com/news/3365643-technology-top-5-gainers-losers-of-2_55-pm-06-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3365643-technology-top-5-gainers-losers-of-2_55-pm-06-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365641\" data-ts=\"1529606336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRTS\" target=\"_blank\">RRTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365641-roadrunner-transportation-breaks-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roadrunner Transportation breaks higher</a></h4><ul><li>Shares of Roadrunner Transportation Systems (NYSE:<a href='https://seekingalpha.com/symbol/RRTS' title='Roadrunner Transportation Systems, Inc.'>RRTS</a>) are&nbsp;<font color='green'>up 12.88%</font>&nbsp;in a notable comeback from some selling pressure earlier this week.</li><li>Trading volume on Roadrunner continues to be above the historic average.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364629-roadrunner-minus-9-percent-former-execs-charged-fraud\" target=\"_blank\">Roadrunner -9% after former execs charged with fraud</a> (June 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365641\" data-linked=\"Roadrunner Transportation breaks higher\" data-tweet=\"$RRTS - Roadrunner Transportation breaks higher https://seekingalpha.com/news/3365641-roadrunner-transportation-breaks-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3365641-roadrunner-transportation-breaks-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365640\" data-ts=\"1529606094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WLK\" target=\"_blank\">WLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365640-westlake-upgraded-bernstein-top-play-on-chinese-pollution-crackdown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westlake upgraded at Bernstein as top play on Chinese pollution crackdown</a></h4><ul>     <li>Westlake Chemical (<a href='https://seekingalpha.com/symbol/WLK' title='Westlake Chemical Corporation'>WLK</a> <font color='green'>+1.8%</font>) is higher after Bernstein initiates shares with an <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/06/11913416/bernstein-westlake-one-of-the-best-plays-on-chinese-pol\" target=\"_blank\">Outperform rating</a> and $150 price target, citing its strong exposure to the chlor-alkali chain which is benefiting from China's pollution crackdown.</li>     <li>China's ambitions to address environmental issues could prove to be the \"most impactful\" event in the chemical industry since the advent of shale gas, the firm says, adding that&nbsp;WLK is \"one of the best ways\" to gain exposure.</li>     <li>The firm also thinks WLK's 71% ownership by the Chao family as a positive since it makes CEO Albert Chao \"highly incentivized\" to perform well and generate strong returns.</li>     <li>Bernstein also starts coverage of Westlake Chemical Partners (<a href='https://seekingalpha.com/symbol/WLKP' title='Westlake Chemical Partners LP'>WLKP</a> <font color='red'>-0.6%</font>) with a Market Perform rating and $25 price target.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365640\" data-linked=\"Westlake upgraded at Bernstein as top play on Chinese pollution crackdown\" data-tweet=\"$WLK $WLK $WLKP - Westlake upgraded at Bernstein as top play on Chinese pollution crackdown https://seekingalpha.com/news/3365640-westlake-upgraded-bernstein-top-play-on-chinese-pollution-crackdown?source=tweet\" data-url=\"https://seekingalpha.com/news/3365640-westlake-upgraded-bernstein-top-play-on-chinese-pollution-crackdown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365639\" data-ts=\"1529605232\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365639-frontierminus-6_7-cfo-resigns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier -6.7% as CFO resigns</a></h4><ul>   <li>Frontier Communications (NYSE:<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a>) is <font color='red'>down 6.7%</font> and matching its lowest point since February following the <a href=\"https://seekingalpha.com/pr/17198790-frontier-communications-announces-resignation-chief-financial-officer\" target=\"_blank\">resignation of its chief financial officer</a>.</li>    <li>R. Perley McBride is exiting his post for personal reasons and returning to his family in Atlanta, the company says.</li>    <li>He'll stay in the job until Aug. 31 to help with transition; the company's searching for a successor.</li>    <li>McBride did a tremendous job with the balance sheet, CEO Daniel McCarthy says: \"He has negotiated improvements in the terms of our credit agreements, raised $1.6B of new second lien debt, and retired approximately $1.7B of unsecured notes.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365639\" data-linked=\"Frontier -6.7% as CFO resigns\" data-tweet=\"$FTR - Frontier -6.7% as CFO resigns https://seekingalpha.com/news/3365639-frontierminus-6_7-cfo-resigns?source=tweet\" data-url=\"https://seekingalpha.com/news/3365639-frontierminus-6_7-cfo-resigns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365636\" data-ts=\"1529604439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNE\" target=\"_blank\">SNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365636-videogame-sales-up-for-2nd-month-hardware-driving\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Videogame sales up for 2nd month with hardware driving</a></h4><ul>   <li>Videogame sales grew for the second straight month overall in May, with continued growth in hardware and accessories more than mitigating a slight drop in software.</li>    <li>Sales rose 13% Y/Y to $685M, according to NPD Group. While software sales fell 4% to $274M, hardware was up 26% to $186M, and accessories sales grew 30% to $225M.</li>    <li>Year-to-date sales are still up across the board (+15% overall, to $4.9B).</li>    <li>Hardware is up 15% YTD to $1.3B; PlayStation 4 (<a href=\"http://seekingalpha.com/symbol/SNE\" target=\"_blank\">SNE</a> <font color='red'>-0.8%</font>) remains the best-selling console hardware platform, while the single best-selling SKU belonged to the Nintendo (<a href=\"http://seekingalpha.com/symbol/NTDOY\" target=\"_blank\">NTDOY</a> <font color='red'>-0.8%</font>) Switch 32GB with Neon Red/Blue JoyCon. Accessories spending is up 29% YTD to $1.4B.</li>    <li>Software was down due to a tough comparable against last year's release of <i>Injustice 2,</i> analyst Mat Piscatella notes. A soft release slate had the dollar sales chart topped by <i>State of Decay 2</i> (<a href=\"http://seekingalpha.com/symbol/MSFT\" target=\"_blank\">MSFT</a> <font color='red'>-0.5%</font>), followed by a pair of Sony (NYSE:<a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a>) releases: <i>God of War 2018</i> and <i>Detroit: Become Human.</i> The No. 4 spot was held down by 2018 best-seller <i>Far Cry 5</i> (<a href=\"http://seekingalpha.com/symbol/UBSFY\" target=\"_blank\">UBSFY</a> <font color='red'>-1.1%</font>), followed by <i>Donkey Kong Country: Tropical Freeze</i> (<a href='https://seekingalpha.com/symbol/NTDOY' title='Nintendo Co., Ltd. ADR'>OTCPK:NTDOY</a>).</li>    <li>Rounding out the top 10 in software: No. 6, <i>Grand Theft Auto V</i> (<a href=\"http://seekingalpha.com/symbol/TTWO\" target=\"_blank\">TTWO</a> <font color='red'>-0.8%</font>); No. 7, <i>Hyrule Warriors Definitive Edition</i> (<a href='https://seekingalpha.com/symbol/NTDOY' title='Nintendo Co., Ltd. ADR'>OTCPK:NTDOY</a>); No. 8, <i>Tom Clancy's Rainbox Six: Siege</i> (<a href='https://seekingalpha.com/symbol/UBSFY' title='UbiSoft Entertainment Inc. ADR'>OTCPK:UBSFY</a>), No. 9, <i>Mario Kart 8</i> (<a href='https://seekingalpha.com/symbol/NTDOY' title='Nintendo Co., Ltd. ADR'>OTCPK:NTDOY</a>), and No. 10, <i>NBA 2K18</i> (NASDAQ:<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a>).</li>    <li>Related tickers: <a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a> <font color='red'>-1.4%</font>, <a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a> <font color='red'>-0.3%</font>, <a href='https://seekingalpha.com/symbol/CCOEY' title='Capcom Co. Ltd ADR'>OTCPK:CCOEY</a> <font color='green'>+6.7%</font>, <a href='https://seekingalpha.com/symbol/NCBDY' title='Bandai Namco Holdings, Inc. ADR'>OTC:NCBDY</a></li>    <li>ETF: <a href='https://seekingalpha.com/symbol/GAMR' title='PureFunds Video Game Tech ETF'>GAMR</a> <font color='red'>-0.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365636\" data-linked=\"Videogame sales up for 2nd month with hardware driving\" data-tweet=\"$SNE $SNE $NTDOY - Videogame sales up for 2nd month with hardware driving https://seekingalpha.com/news/3365636-videogame-sales-up-for-2nd-month-hardware-driving?source=tweet\" data-url=\"https://seekingalpha.com/news/3365636-videogame-sales-up-for-2nd-month-hardware-driving\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365632\" data-ts=\"1529604045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNGR\" target=\"_blank\">RNGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365632-energy-materials-top-gainers-losers-of-2-00-pm-06-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 PM (06/21/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RNGR' title='Ranger Energy Services'>RNGR</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/YTEN' title='Yield10 Bioscience, Inc.'>YTEN</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/EPE' title='EP Energy Corporation'>EPE</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/DWSN' title='Dawson Geophysical Company'>DWSN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/GPRK' title='GeoPark Ltd.'>GPRK</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365632\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 PM (06/21/2018)\" data-tweet=\"$RNGR $RNGR $YTEN - Energy/Materials - Top Gainers / Losers as of 2:00 PM (06/21/2018) https://seekingalpha.com/news/3365632-energy-materials-top-gainers-losers-of-2-00-pm-06-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3365632-energy-materials-top-gainers-losers-of-2-00-pm-06-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365629\" data-ts=\"1529603647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PF\" target=\"_blank\">PF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365629-pinnacle-foodplus-3-amid-conagra-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pinnacle Food +3% amid ConAgra talk</a></h4><ul><li>Pinnacle Foods (<a href='https://seekingalpha.com/symbol/PF' title='Pinnacle Foods'>PF</a> <font color='green'>+2.5%</font>) trades higher after Bloomberg reports that the company has held talks recently with ConAgra Brands (<a href='https://seekingalpha.com/symbol/CAG' title='ConAgra Brands, Inc.'>CAG</a>).</li><li>Speculation on a PF-CAG deal has lingered for a few months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365629\" data-linked=\"Pinnacle Food +3% amid ConAgra talk\" data-tweet=\"$PF $PF $CAG - Pinnacle Food +3% amid ConAgra talk https://seekingalpha.com/news/3365629-pinnacle-foodplus-3-amid-conagra-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/3365629-pinnacle-foodplus-3-amid-conagra-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365627\" data-ts=\"1529602496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSTK\" target=\"_blank\">OSTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365627-overstock-com-reacts-to-scotus-decision\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Overstock.com reacts to SCOTUS decision</a></h4><ul><li>Overstock.com (<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a> <font color='red'>-6.8%</font>) calls on Congress to intervene and legislate a fair solution in the wake of today&rsquo;s Supreme Court ruling on online sales tax collection, which it says could impact on innovative internet startups.</li>   <li>&ldquo;Though the impact of the Court&rsquo;s ruling today will be clarified by further proceedings in the lower court, we are prepared to comply with any outcome, and the decision will have no appreciable impact on our business,&rdquo; says Overstock.com board member Jonathan Johnson.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17198780-overstock-com-urges-congressional-action-following-u-s-supreme-court-ruling\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3365627\" data-linked=\"Overstock.com reacts to SCOTUS decision\" data-tweet=\"$OSTK - Overstock.com reacts to SCOTUS decision https://seekingalpha.com/news/3365627-overstock-com-reacts-to-scotus-decision?source=tweet\" data-url=\"https://seekingalpha.com/news/3365627-overstock-com-reacts-to-scotus-decision\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365623\" data-ts=\"1529601799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVTZF\" target=\"_blank\">EVTZF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365623-on-evertz-technologiess-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Evertz Technologies&#39;s Q4 results</a></h4><ul><li>Evertz Technologies (<a href='https://seekingalpha.com/symbol/EVTZF' title='Evertz Technologies Ltd.'>OTCPK:EVTZF</a>) reported  Q4 revenue of C$93M (-12.9% Y/Y). Region wise revenue: US/Canada C$52.1M (-10% Y/Y) and International C$40.9M (-16.4% Y/Y).</li><li>Q4 Overall margins: Gross&nbsp;<font color='red'>declined by 355 bps</font>&nbsp;to 52.7% and operating margin&nbsp;<font color='red'>declined by 1,330 bps</font>&nbsp;to 12.5%.</li><li>Q4 expenses: S&amp;A was C$17.83M (+8.53% Y/Y), General C$1.98M (-18.1% Y/Y) and R&amp;D C$21.02M (+5.4% Y/Y).</li><li>Purchase order backlog was C$85M at the end of May 2018.</li><li>Shipments for the month of May 2018 were C$32M.</li><li>Cash and cash equivalents were C$94.2M as of April 30, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365044-evertz-technologies-reports-q4-results\" target=\"_blank\">Evertz Technologies reports Q4 results</a> (June 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365623\" data-linked=\"More on Evertz Technologies&#39;s Q4 results\" data-tweet=\"$EVTZF - More on Evertz Technologies&#39;s Q4 results https://seekingalpha.com/news/3365623-on-evertz-technologiess-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3365623-on-evertz-technologiess-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365619\" data-ts=\"1529600452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BFR\" target=\"_blank\">BFR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365619-financials-top-5-gainers-losers-of-1-00-pm-06-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (06/21/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco Francs S.A.  ADR'>BFR</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/IRS' title='IRSA Inversiones Y Representaciones S.A.'>IRS</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ACGL' title='Arch Capital Group Ltd.'>ACGL</a> <font color='red'>-68%</font>. <a href='https://seekingalpha.com/symbol/DNJR' title='Golden Bull Ltd'>DNJR</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MC' title='Moelis & Company'>MC</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365619\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (06/21/2018)\" data-tweet=\"$BFR $BBAR $SUPV - Financials - Top 5 Gainers / Losers as of 1:00 PM (06/21/2018) https://seekingalpha.com/news/3365619-financials-top-5-gainers-losers-of-1-00-pm-06-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3365619-financials-top-5-gainers-losers-of-1-00-pm-06-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365615\" data-ts=\"1529599933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STMP\" target=\"_blank\">STMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365615-stamps-comminus-12-on-threat-of-post-office-restructuring\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stamps.com -12% on threat of post office restructuring</a></h4><ul> <li>Shares of Stamps.com (NASDAQ:<a href='https://seekingalpha.com/symbol/STMP' title='Stamps.com Inc.'>STMP</a>) are&nbsp;<font color='red'>down 12.20%</font>&nbsp;after the White House <a href=\"https://www.bloomberg.com/news/articles/2018-06-21/trump-calls-for-combining-education-labor-departments-in-revamp\" target=\"_blank\">proposes</a> a restructuring of the U.S. Postal Service.</li> <li>The plan from the Trump Administration could include a privatization of some mail delivery.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3365615\" data-linked=\"Stamps.com -12% on threat of post office restructuring\" data-tweet=\"$STMP - Stamps.com -12% on threat of post office restructuring https://seekingalpha.com/news/3365615-stamps-comminus-12-on-threat-of-post-office-restructuring?source=tweet\" data-url=\"https://seekingalpha.com/news/3365615-stamps-comminus-12-on-threat-of-post-office-restructuring\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365611\" data-ts=\"1529599310\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBIO\" target=\"_blank\">XBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365611-midday-gainers-losers-06-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (06/21/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a> <font color='green'>+151%</font>. <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+79%</font>. <a href='https://seekingalpha.com/symbol/ASCMA' title='Ascent Capital Group, Inc.'>ASCMA</a> <font color='green'>+48%</font>. <a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies Inc.'>SBOT</a> <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/RYTM' title='Rhythm Pharmaceuticals, Inc.'>RYTM</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/BNED' title='Barnes & Noble Education, Inc'>BNED</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight'>BOXL</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco Francs S.A.  ADR'>BFR</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/AVLR' title='Avalara'>AVLR</a> <font color='green'>+14%</font>.</li> &nbsp;     <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a> <font color='red'>-46%</font>. <a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/CLPS' title='CLPS, Inc'>CLPS</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/CLBS' title='Caladrius Biosciences, Inc.'>CLBS</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/AETI' title='American Electric Technologies, Inc.'>AETI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ARDM' title='Aradigm Corp.'>OTC:ARDM</a> <font color='red'>-15%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3365611\" data-linked=\"Midday Gainers / Losers (06/21/2018)\" data-tweet=\"$XBIO $XBIO $ABIL - Midday Gainers / Losers (06/21/2018) https://seekingalpha.com/news/3365611-midday-gainers-losers-06-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3365611-midday-gainers-losers-06-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365609\" data-ts=\"1529598598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LMNR\" target=\"_blank\">LMNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365609-limoneira-expands-globally-chilean-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Limoneira expands globally with Chilean acquisition</a></h4><ul>     <li>Limoneira (<a href='https://seekingalpha.com/symbol/LMNR' title='Limoneira'>LMNR</a> <font color='red'>-5.8%</font>) to <a href=\"http://investor.limoneira.com/news-releases/news-release-details/limoneira-expands-globally-accretive-chilean-acquisition\" target=\"_blank\">acquire</a> a ranch and related assets of Fruticola San Pablo S.A in La Serena, Chile for $13M.</li>     <li>The San Pablo ranch consists of 3,317 total acres on two parcels, including 247 acres producing lemons, 61 acres producing oranges, the opportunity to immediately plant 120 acres for lemon production, as well as the potential for ~500 acres of avocado production.</li>     <li>The Company expects the acquisition to add $0.02 - $0.03 in EPS in fiscal 2018, and $0.06 - $0.08 in fiscal 2019.&nbsp;&nbsp;The acquisition is expected to close in July 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365381-limoneira-lower-50m-public-share-offering\" target=\"_blank\">Limoneira lower on $50M public share offering</a> (June 20)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365609\" data-linked=\"Limoneira expands globally with Chilean acquisition\" data-tweet=\"$LMNR - Limoneira expands globally with Chilean acquisition https://seekingalpha.com/news/3365609-limoneira-expands-globally-chilean-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3365609-limoneira-expands-globally-chilean-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365608\" data-ts=\"1529598238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHPG\" target=\"_blank\">SHPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365608-shire-boosts-plasma-manufacturing-capacity-30-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shire boosts plasma manufacturing capacity 30%; shares up 1%</a></h4><ul><li>Shire plc (<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='green'>+1.4%</font>) is up on below-average volume on the heels of its <a href=\"https://seekingalpha.com/pr/17198688-shire-receives-u-s-fda-approval-new-state-art-plasma-manufacturing-facility-near-covington\" target=\"_blank\">announcement </a>that that FDA has signed off on its new plasma manufacturing facility that will make GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% Solution, a replacement therapy for primary humoral immunodeficiency.</li><li>The Covington, GA-located operation will add 30% to its internal plasma manufacturing capacity after production ramps up.</li><li>Later this year, the company plans to submit another application to the FDA seeking approval to make its albumin therapy there.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365608\" data-linked=\"Shire boosts plasma manufacturing capacity 30%; shares up 1%\" data-tweet=\"$SHPG - Shire boosts plasma manufacturing capacity 30%; shares up 1% https://seekingalpha.com/news/3365608-shire-boosts-plasma-manufacturing-capacity-30-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3365608-shire-boosts-plasma-manufacturing-capacity-30-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365607\" data-ts=\"1529597983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLPS\" target=\"_blank\">CLPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365607-clps-erases-40-of-yesterdays-gain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CLPS erases about 40% of yesterday&#39;s gain</a></h4><ul><li>CLPS (NASDAQ:<a href='https://seekingalpha.com/symbol/CLPS' title='CLPS, Inc'>CLPS</a>)<font color='red'> sinks 18%</font>&nbsp;a day after it surged by 56%, when the company released a letter to shareholders outlining expansion plans.</li><li>The China-based fintech company went public at $5.25 a share on June 4.</li><li>Volume at midday 917,886; its average since going public on June 4 is 2.32M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365231-clps-surges-26-percent-letter-shareholders-discusses-expansion-plans\" target=\"_blank\">CLPS surges 26% as letter to shareholders discusses expansion plans</a> (June 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365607\" data-linked=\"CLPS erases about 40% of yesterday&#39;s gain\" data-tweet=\"$CLPS - CLPS erases about 40% of yesterday&#39;s gain https://seekingalpha.com/news/3365607-clps-erases-40-of-yesterdays-gain?source=tweet\" data-url=\"https://seekingalpha.com/news/3365607-clps-erases-40-of-yesterdays-gain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365605\" data-ts=\"1529597545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNVA\" target=\"_blank\">RNVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365605-rennova-health-down-14_7-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rennova Health down 14.7% post Q1 results</a></h4><ul><li>Rennova Health (<a href='https://seekingalpha.com/symbol/RNVA' title='Rennova Health, Inc.'>OTCPK:RNVA</a> <font color='red'>-14.7%</font>)&nbsp;<a href=\"https://seekingalpha.com/filing/4073118\" target=\"_blank\">reports Q1</a> revenue growth of 135.3% Y/Y to $1.6M.</li><li>G&amp;A expenses decreased 13% Y/Y to $2.9M &amp; and also&nbsp;there was a decline in S&amp;M expenses of ~100% Y/Y.</li><li>Bad debt expense was $0.6M, as compared to zero Y/Y, the increase is related to allowance for doubtful accounts and allowance billing adjustments by insurance companies.</li><li>The company completed the acquisition of second rural hospital in Jamestown, Tennessee at a total cost of ~$1.1M from Community Health Systems.</li><li>Also, raised $3M in private placements of convertible notes &amp; increased authorized common stock to 3B shares.</li><li>Separated and progressed plans to spin out two divisions, Genetic diagnostics and interpretation and the Software division.</li><li>For Q1, the company had $35K in cash on hand from continuing operations; a working capital deficit of $174.8M and a stockholders deficit of $183.9M.</li><li>Also, incurred a loss from continuing operations of $3.7M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365056-rennova-health-reports-q1-results\" target=\"_blank\">Rennova Health reports Q1 results</a> (June 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365605\" data-linked=\"Rennova Health down 14.7% post Q1 results\" data-tweet=\"$RNVA - Rennova Health down 14.7% post Q1 results https://seekingalpha.com/news/3365605-rennova-health-down-14_7-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3365605-rennova-health-down-14_7-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365602\" data-ts=\"1529597102\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALKS\" target=\"_blank\">ALKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365602-alkermes-slumps-12-after-ms-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alkermes slumps 12% after MS downgrade</a></h4><ul><li>Alkermes plc (<a href='https://seekingalpha.com/symbol/ALKS' title='Alkermes plc'>ALKS</a> <font color='red'>-11.7%</font>) is down on average volume on the heels of a downgrade to Underweight at Morgan Stanley. Analyst David Risinger also lowered his price target to $42 (8% downside risk) from $67 citing growth concerns with top seller Vivitrol and risks of negative news on late-stage candidates in schizophrenia and depression in the coming months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365602\" data-linked=\"Alkermes slumps 12% after MS downgrade\" data-tweet=\"$ALKS - Alkermes slumps 12% after MS downgrade https://seekingalpha.com/news/3365602-alkermes-slumps-12-after-ms-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3365602-alkermes-slumps-12-after-ms-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365601\" data-ts=\"1529596848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FAMI\" target=\"_blank\">FAMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365601-consumer-top-gainers-losers-of-12-00-pm-06-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (06/21/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi Inc.'>FAMI</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/EAST' title='Eastside Distilling, Inc.'>EAST</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CRESY' title='Cresud S.A.C.I.F. y A.'>CRESY</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SCS' title='Steelcase Inc.'>SCS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365601\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (06/21/2018)\" data-tweet=\"$FAMI $FAMI $EAST - Consumer - Top Gainers / Losers as of 12:00 PM (06/21/2018) https://seekingalpha.com/news/3365601-consumer-top-gainers-losers-of-12-00-pm-06-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3365601-consumer-top-gainers-losers-of-12-00-pm-06-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365598\" data-ts=\"1529596100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HES\" target=\"_blank\">HES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365598-focus-on-returns-now-to-hurt-long-term-u-s-shale-investment-hess-ceo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Focus on returns now to hurt long-term U.S. shale investment, Hess CEO says</a></h4><ul>     <li>Investor pressure on oil producers to focus more attention on shareholder returns and less on production will <a href=\"https://www.reuters.com/article/us-oil-opec-hess/focus-on-returns-now-will-hurt-long-term-u-s-shale-oil-investment-hess-idUSKBN1JH1DB\" target=\"_blank\">drive down needed investment</a> over the long term, Hess (<a href='https://seekingalpha.com/symbol/HES' title='Hess Corporation'>HES</a> <font color='red'>-1.5%</font>)&nbsp;CEO&nbsp;John Hess says at the OPEC meeting in Vienna.</li>     <li>&ldquo;Investor sentiment in the last year has really, markedly changed. I&rsquo;d say it&rsquo;s gone from, &lsquo;drill, baby, drill,&rsquo; to &lsquo;show me the money,&rsquo;&rdquo; Hess says. &ldquo;While that financial discipline is healthy, I think it does act like a brake on long-term investment.\"</li><li>&ldquo;There&rsquo;s a worldwide obsession with shale. In the U.S., it&rsquo;s irrational  exuberance, and in other countries it&rsquo;s irrational fear,&rdquo; Hess also says,  adding that he does not expect the industry to gain traction in other  countries.</li><li>Hess does not operate in any OPEC member nation but is still sponsoring an oil seminar at this week's meeting.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365598\" data-linked=\"Focus on returns now to hurt long-term U.S. shale investment, Hess CEO says\" data-tweet=\"$HES - Focus on returns now to hurt long-term U.S. shale investment, Hess CEO says https://seekingalpha.com/news/3365598-focus-on-returns-now-to-hurt-long-term-u-s-shale-investment-hess-ceo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3365598-focus-on-returns-now-to-hurt-long-term-u-s-shale-investment-hess-ceo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365597\" data-ts=\"1529596012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYT\" target=\"_blank\">NYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365597-nyt-11-year-high-huber-pivots-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NYT at 11-year high; Huber pivots to Buy</a></h4><ul>   <li>The New York Times Co. (NYSE:<a href='https://seekingalpha.com/symbol/NYT' title='New York Times Co.'>NYT</a>) is <font color='green'>up 2%</font> and at its highest point in 11 years alongside a two-notch upgrade from Huber Research, to Overweight.</li>    <li>The firm's Douglas Arthur sees positives not only from digital subscriptions driven by the election, but also advertising and real estate. Next year the company has the option to repay a 10-year $250M leaseback and reclaim ownership of its headquarters (which he values at $1B) at the 2009 price, he says. (h/t Bloomberg)</li>    <li>He also notes the stock has performed despite heavy selling by the likes of Carlos Slim (10M shares this year).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365597\" data-linked=\"NYT at 11-year high; Huber pivots to Buy\" data-tweet=\"$NYT - NYT at 11-year high; Huber pivots to Buy https://seekingalpha.com/news/3365597-nyt-11-year-high-huber-pivots-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3365597-nyt-11-year-high-huber-pivots-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365594\" data-ts=\"1529594958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365594-intel-announces-upside-preliminary-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel announces upside preliminary Q2 results</a></h4><ul><li>Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>)&nbsp;<a href=\"https://seekingalpha.com/pr/17198352-intel-ceo-brian-krzanich-resigns-board-appoints-bob-swan-interim-ceo\" target=\"_blank\">preannounced</a> Q2 results earlier today when it announced the resignation of CEO Brian Krzanich.</li><li>Intel expects $16.9B in revenue (consensus: $16.29B) and EPS of $0.99 (consensus: $0.85).</li><li>Intel shares are&nbsp;<font color='red'>down 1.7%</font>&nbsp;to $52.52.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365594-intel-announces-upside-preliminary-q2-results\" target=\"_blank\">Intel announces upside preliminary Q2 results</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365594\" data-linked=\"Intel announces upside preliminary Q2 results\" data-tweet=\"$INTC - Intel announces upside preliminary Q2 results https://seekingalpha.com/news/3365594-intel-announces-upside-preliminary-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3365594-intel-announces-upside-preliminary-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365593\" data-ts=\"1529594917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEO\" target=\"_blank\">CEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365593-cnoocs-nexen-to-move-forward-c-400m-canada-oil-sands-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cnooc&#39;s Nexen to move forward with C$400M Canada oil sands project</a></h4><ul>     <li>Cnooc's (<a href='https://seekingalpha.com/symbol/CEO' title='CNOOC Limited'>CEO</a> <font color='red'>-3%</font>) Nexen Energy says it <a href=\"http://business.financialpost.com/commodities/energy/rare-foreign-investment-in-the-oilsands-as-nexen-proceeds-with-400m-expansion\" target=\"_blank\">will move ahead with work</a> on a new C$400M (US$300M) expansion of its Long Lake project in Alberta, marking a rare return of foreign direct investment to Canada's oil sands.</li>     <li>Nexen says the expansion will add 26K bbl/day to production at Long Lake, with first oil expected in late 2020.</li>     <li>The decision shows Cnooc's willingness to invest in the oil sands and thus is a positive sign for the sector, and suggests some companies are starting to proceed with their mothballed  projects as U.S. crude oil prices stay well above $60/bbl, says Kevin Birn, VP of North American crude oil markets at IHS Markit.</li><li>The per-barrel costs of the new project are 50% lower than what  Nexen was paying for expansion projects before the 2014 oil price collapse, Birn says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365593\" data-linked=\"Cnooc&#39;s Nexen to move forward with C$400M Canada oil sands project\" data-tweet=\"$CEO - Cnooc&#39;s Nexen to move forward with C$400M Canada oil sands project https://seekingalpha.com/news/3365593-cnoocs-nexen-to-move-forward-c-400m-canada-oil-sands-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3365593-cnoocs-nexen-to-move-forward-c-400m-canada-oil-sands-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365589\" data-ts=\"1529594718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNWEF\" target=\"_blank\">HNWEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365589-hanwei-energy-services-slides-82-post-fy-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hanwei Energy Services slides 82% post FY results</a></h4><ul><li>Hanwei Energy Services (<a href='https://seekingalpha.com/symbol/HNWEF' title='Hanwei Energy Services Corp.'>OTC:HNWEF</a>)&nbsp;<a href=\"https://seekingalpha.com/pr/17197798-hanwei-energy-services-reports-year-end-fiscal-2018-financial-operational-results\" target=\"_blank\">reports FY</a> revenue growth of 41.2% Y/Y to C$10.6M, the increase was driven by the growth in FRP pipe sales, primarily in the Company&rsquo;s&nbsp;China&nbsp;market.</li><li>Total Pipe revenue was C$9.1M (+82% Y/Y) &amp; Oil and Gas of C$1.5M (-40% Y/Y).</li><li>Revenues from the Company&rsquo;s China FRP pipe market increased by 281% Y/Y to C$6.6M whereas, revenues from the Canadian FRP pipe market decreased 42% Y/Y to ~C$1.8M.</li><li>Total adj. EBITDA margin<font color='green'> improved 1,400 bps</font>&nbsp;to 3%; for Pipe&nbsp;<font color='green'>increased 1,900 bps</font>&nbsp;to 21% &amp;&nbsp;<font color='red'>declined 4,700 bps</font>&nbsp;to -46% for Oil and Gas.</li><li>In 2018, the Company produced ~107boe/d (-50.9% Y/Y), including 58 bbl/d of oil (-28.4% Y/Y), 224 mcf/d of gas (-63.3% Y/Y) and 12 boe/d of liquids (-65.7% Y/Y).</li><li>The Company brought its&nbsp;Leduc Lands&nbsp;back on test production on May 19, 2018. &nbsp;Test production oil volume is currently at ~250 bbl/d.</li><li>The total principal amount of all short-term loans was C$5.1M representing a 38% debt to equity ratio.</li><li>Cash and equivalents was ~C$1M&nbsp;&amp; the company had a Net Asset Value per share for its continuing operations of C$0.13.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365396-hanwei-energy-services-reports-fy-results\" target=\"_blank\">Hanwei Energy Services reports FY results</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365589\" data-linked=\"Hanwei Energy Services slides 82% post FY results\" data-tweet=\"$HNWEF - Hanwei Energy Services slides 82% post FY results https://seekingalpha.com/news/3365589-hanwei-energy-services-slides-82-post-fy-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3365589-hanwei-energy-services-slides-82-post-fy-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365590\" data-ts=\"1529594543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASCMA\" target=\"_blank\">ASCMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365590-ascent-capital-bounces-53-from-52-week-low-still-down-83-from-52-week-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ascent Capital bounces 53% from 52-week low, still down 83% from 52-week high</a></h4><ul><li>Ascent Capital Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ASCMA' title='Ascent Capital Group, Inc.'>ASCMA</a>)<font color='green'> rises 53%</font>&nbsp;to $2.60 in late morning trading on volume more than 10 times' its three-month daily average, a bit of bounce from yesterday's 52-week low of $1.68.</li><li>Today's gain makes little progress in regaining ground lost in the past 11 months. ASMA's 52-week high was $17.84 on July 25..</li><li>Previously: <a href=\"https://seekingalpha.com/news/3354197-ascent-capital-misses-1_12-beats-revenue\" target=\"_blank\">Ascent Capital misses by $1.12, beats on revenue</a> (May 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365590\" data-linked=\"Ascent Capital bounces 53% from 52-week low, still down 83% from 52-week high\" data-tweet=\"$ASCMA $SCTY - Ascent Capital bounces 53% from 52-week low, still down 83% from 52-week high https://seekingalpha.com/news/3365590-ascent-capital-bounces-53-from-52-week-low-still-down-83-from-52-week-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3365590-ascent-capital-bounces-53-from-52-week-low-still-down-83-from-52-week-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365584\" data-ts=\"1529593875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVLR\" target=\"_blank\">AVLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365584-avalara-soars-after-scotus-ruling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avalara soars after SCOTUS ruling</a></h4><ul> <li>Avalara (NYSE:<a href='https://seekingalpha.com/symbol/AVLR' title='Avalara'>AVLR</a>)&nbsp;<font color='green'>skies 28.1%</font>&nbsp;after the Supreme Court rules that states can enforce the collection of online sales tax.</li> <li>Shares of AVLR hit a post-IPO high of $58.22 off the expectation that the company's business will take off due to the SCOTUS ruling.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3365584\" data-linked=\"Avalara soars after SCOTUS ruling\" data-tweet=\"$AVLR - Avalara soars after SCOTUS ruling https://seekingalpha.com/news/3365584-avalara-soars-after-scotus-ruling?source=tweet\" data-url=\"https://seekingalpha.com/news/3365584-avalara-soars-after-scotus-ruling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365579\" data-ts=\"1529593247\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBIO\" target=\"_blank\">XBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365579-healthcare-top-5-gainers-losers-of-11-00-06-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/21/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a> <font color='green'>+164%</font>. <a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies Inc.'>SBOT</a> <font color='green'>+61%</font>. <a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/RYTM' title='Rhythm Pharmaceuticals, Inc.'>RYTM</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/CASI' title='CASI Pharmaceuticals'>CASI</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a> <font color='red'>-44%</font>. <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='red'>-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365579\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/21/2018)\" data-tweet=\"$XBIO $XBIO $EDSA - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/21/2018) https://seekingalpha.com/news/3365579-healthcare-top-5-gainers-losers-of-11-00-06-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3365579-healthcare-top-5-gainers-losers-of-11-00-06-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365574\" data-ts=\"1529592533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPRT\" target=\"_blank\">EPRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365574-essential-properties-initial-trade-falls-short-of-ipo-price\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Essential Properties initial trade falls short of IPO price</a></h4><ul><li>Essential Properties Realty Trust's (NYSE:<a href='https://seekingalpha.com/symbol/EPRT' title='Essential Properties Realty Trust'>EPRT</a>) opens trading on NYSE at&nbsp;<font color='red'>3.6% below</font>&nbsp;its initial public offering price of $14.00.</li><li>EPRT<a href=\"https://seekingalpha.com/pr/17197836-essential-properties-realty-trust-inc-announces-pricing-initial-public-offering\" target=\"_blank\"> sold 32.5M shares</a> of common stock in its public offering. Together with a private offering of shares and common units of its Eldridge Industries unit, the company raised $542.7M.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17197836-b-essential-b-b-properties-b-realty-trust-inc-announces-pricing-initial-public-offering\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3365574\" data-linked=\"Essential Properties initial trade falls short of IPO price\" data-tweet=\"$EPRT - Essential Properties initial trade falls short of IPO price https://seekingalpha.com/news/3365574-essential-properties-initial-trade-falls-short-of-ipo-price?source=tweet\" data-url=\"https://seekingalpha.com/news/3365574-essential-properties-initial-trade-falls-short-of-ipo-price\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365573\" data-ts=\"1529592523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365573-analysts-raise-micron-price-targets-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts raise Micron price targets after earnings</a></h4><ul><li>        JPMorgan <a href=\"https://www.cnbc.com/2018/06/21/micron-jumps-as-wall-street-gushes-over-cloud-memory-demand.html\" target=\"_blank\">reiterates</a> its Overweight rating for Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) after earnings and raises the price target from $82 to $84, a 43% upside to yesterday&rsquo;s close.</li><li>               Analyst Harlan Sur says the company continues to benefit from &ldquo;strong cloud data center demand with cloud DRAM revenues up 33% Q/Q.&rdquo;&nbsp;</li><li>               Sur: &ldquo;In terms of the industry environment, we expect broader memory fundamentals to remain constructive into next year led by continued demand strength in data center.&rdquo;&nbsp;</li><li>               Stifel reaffirms its Buy rating and raises its Micron target by $2 to $108.&nbsp;</li><li>               Analyst Kevin Cassidy also cites cloud spending as a continued tailwind.&nbsp;</li><li>               Mizuho maintains a Buy rating and raises its target by $2 to $72.&nbsp;</li><li>               Analyst Vijay Rakesh: &ldquo;We continue to see DRAM and NAND spot pricing relatively stable as we move through the JunQ and into 2H18, which would be much better than initial fears.&rdquo;&nbsp;</li><li>               Micron shares are&nbsp;<font color='green'>up 2%</font>&nbsp;to $60.11.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365351-micron-dips-despite-q3-beats-nand-dram-shipments-flat-q-q\" target=\"_blank\">Micron dips despite Q3 beats; NAND and DRAM shipments flat Q/Q</a> (June 20)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365436-micron-plus-4_8-percent-earnings-upside-q4-guidance\" target=\"_blank\">Micron +4.8% after earnings, upside Q4 guidance</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365573\" data-linked=\"Analysts raise Micron price targets after earnings\" data-tweet=\"$MU - Analysts raise Micron price targets after earnings https://seekingalpha.com/news/3365573-analysts-raise-micron-price-targets-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3365573-analysts-raise-micron-price-targets-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>129&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365571\" data-ts=\"1529592414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365571-cnbc-ge-may-not-break-up-completely-announce-spinoff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNBC: GE may not break up completely but could announce spinoff</a></h4><ul>     <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-1.7%</font>) slides to a fresh 52-week low as CNBC's David Faber reports the company is expected to make a <a href=\"https://www.cnbc.com/2018/06/21/ge-may-not-break-up-completely-but-could-announce-spin-off.html\" target=\"_blank\">significant announcement about its future</a> by the end of Q2.</li><li>The news may not amount to the full break-up that some had anticipated but it would be a \"significant announcement around reorganization of the  company, including potentially something being spun,\" according to Faber.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365571\" data-linked=\"CNBC: GE may not break up completely but could announce spinoff\" data-tweet=\"$GE - CNBC: GE may not break up completely but could announce spinoff https://seekingalpha.com/news/3365571-cnbc-ge-may-not-break-up-completely-announce-spinoff?source=tweet\" data-url=\"https://seekingalpha.com/news/3365571-cnbc-ge-may-not-break-up-completely-announce-spinoff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365570\" data-ts=\"1529592355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMC\" target=\"_blank\">AMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365570-amc-entertainment-completes-sale-leaseback-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMC Entertainment completes sale-leaseback deal</a></h4><ul> <li>AMC Entertainment (<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc'>AMC</a> <font color='green'>+2.9%</font>) announces that it completed a $53M transaction to sell and       simultaneously lease back a single AMC theatre in a major U.S.       metropolitan area.</li><li>The company says the sale leaseback transaction is consistent with       similar sale leaseback agreements completed in the fall of 2017 for       seven AMC theatres.</li>     <li>The latest transaction brings the total of AMC&rsquo;s       non-strategic asset sales in the past ten and a half months to       approximately $495M, when combined with seven previously       announced transactions</li><li>Source: <a href=\"https://seekingalpha.com/pr/17198528-amc-entertainment-holdings-inc-completes-sale-leaseback-agreement-53-million\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3365570\" data-linked=\"AMC Entertainment completes sale-leaseback deal\" data-tweet=\"$AMC - AMC Entertainment completes sale-leaseback deal https://seekingalpha.com/news/3365570-amc-entertainment-completes-sale-leaseback-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3365570-amc-entertainment-completes-sale-leaseback-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365550\" data-ts=\"1529591836\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BNED\" target=\"_blank\">BNED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365550-barnes-noble-education-up-15_4-post-fy-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp; Noble Education up 15.4% post FY results</a></h4><ul><li>Barnes &amp; Noble Education (<a href='https://seekingalpha.com/symbol/BNED' title='Barnes & Noble Education, Inc'>BNED</a> <font color='green'>+15.4%</font>)&nbsp;<a href=\"https://seekingalpha.com/filing/4073853\" target=\"_blank\">reports FY</a> revenue growth of 17.6% Y/Y to $2.2B.</li><li>Segment revenue: BNC of $1.8B (-1.6% Y/Y); MBS of $459.5M (+1247% Y/Y) &amp; DSS of $15.8M.</li><li>Segment Adj. EBITDA margin: BNC&nbsp;<font color='red'>declined 102 bps</font>&nbsp;to 4.8%; MBS&nbsp;<font color='green'>increased 2,244 bps</font>&nbsp;to 11.9% &amp; for DSS there is no comparison, as Student Brands was acquired subsequent to the end of 2017.</li><li>Total Adj. EBITDA&nbsp;<font color='green'>increased 157 bps</font>&nbsp;to 5.8%, the increase was primarily attributable to the full year contributions from MBS and Student Brands and lower Corporate Services, partially offset by the decreases at BNC.</li><li>Comparable store sales for BNC decreased 4.1%, driven primarily by enrollment declines, especially at community colleges, and the overall decline in textbook average sales prices.</li><li>Also, recognized benefits of the synergies and integration of MBS, with MBS delivering $459.5M of sales and $54.6M of Adj. EBITDA.</li><li>Expanded available LoudCloud Courseware to 32 course offerings and significantly reduced pricing consistent with the Company&rsquo;s ongoing mission to drive affordability and accessibility on campuses nationwide.</li><li>2019 Outlook: Sales to be $2.2-2.3M; Adj. EBITDA of $110-125M &amp; Capex of ~$60M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365332-barnes-and-noble-education-beats-revenue\" target=\"_blank\">Barnes &amp; Noble Education beats on revenue</a> (June 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365550\" data-linked=\"Barnes &amp; Noble Education up 15.4% post FY results\" data-tweet=\"$BNED - Barnes &amp; Noble Education up 15.4% post FY results https://seekingalpha.com/news/3365550-barnes-noble-education-up-15_4-post-fy-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3365550-barnes-noble-education-up-15_4-post-fy-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365561\" data-ts=\"1529591736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365561-twitter-to-buy-anti-abuse-software-firm-smyte\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter to buy anti-abuse software firm Smyte</a></h4><ul>   <li>Twitter (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color='red'>-3.2%</font>) has <a href=\"https://techcrunch.com/2018/06/21/twitter-acquires-anti-abuse-technology-provider-smyte/\" target=\"_blank\">agreed to buy</a> anti-abuse software firm Smyte.</li>    <li>It's the company's first acquisition since Yes Inc., a year and a half ago.</li>    <li>Smyte was founded by engineers with backgrounds in spam, fraud and security; its addition could shore up what has been a frequent user complaint, that Twitter is slow to deal with abusive and harassing behavior (not to mention trolls and bots) on the platform.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365561\" data-linked=\"Twitter to buy anti-abuse software firm Smyte\" data-tweet=\"$TWTR - Twitter to buy anti-abuse software firm Smyte https://seekingalpha.com/news/3365561-twitter-to-buy-anti-abuse-software-firm-smyte?source=tweet\" data-url=\"https://seekingalpha.com/news/3365561-twitter-to-buy-anti-abuse-software-firm-smyte\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365553\" data-ts=\"1529591422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365553-eia-natural-gas-inventory\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Natural Gas Inventory</a></h4><ul>     <li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory</a>: <strong>+91 Bcf</strong> vs. +85 Bcf consensus, +96 Bcf last week.</li><li>Futures&nbsp;<font color='green'>+1.28%</font>&nbsp;to $3.002.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365553\" data-linked=\"EIA Natural Gas Inventory\" data-tweet=\"$UNG $DGAZ $UGAZ - EIA Natural Gas Inventory https://seekingalpha.com/news/3365553-eia-natural-gas-inventory?source=tweet\" data-url=\"https://seekingalpha.com/news/3365553-eia-natural-gas-inventory\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365552\" data-ts=\"1529591053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365552-amazon-prime-day-scheduled-for-july-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon Prime Day scheduled for July 16?</a></h4><ul><li>        Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) Prime Day could happen on July 16, according to <a href=\"https://www.techradar.com/news/amazon-prime-day-2018-date-leaked-36-hours-of-deals-start-midday-on-july-16th?utm_content=buffer7e1f4&amp;utm_medium=social&amp;utm_source=twitter.com&amp;utm_campaign=buffer_trtw\" target=\"_blank\">TechRadar</a>.</li><li>               The date was accidentally published on the Amazon U.K. website on a banner.&nbsp;</li><li>               The annual sales event would start midday and continue on through the following day for a total of 36 hours.&nbsp;</li><li>               Amazon shares are&nbsp;<font color='red'>down 1.3%</font>&nbsp;to $1,726.86.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3365552\" data-linked=\"Amazon Prime Day scheduled for July 16?\" data-tweet=\"$AMZN - Amazon Prime Day scheduled for July 16? https://seekingalpha.com/news/3365552-amazon-prime-day-scheduled-for-july-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3365552-amazon-prime-day-scheduled-for-july-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365547\" data-ts=\"1529590459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEO\" target=\"_blank\">AEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365547-ubs-picks-favorite-softlines-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS picks favorite softlines stocks</a></h4><ul> <li>UBS issues a generally favorable assessment on the softlines sector, singling out American Eagle Outfitters (<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='green'>+3%</font>), Tapestry (<a href='https://seekingalpha.com/symbol/TPR' title='Tapestry, Inc.'>TPR</a> <font color='green'>+2.1%</font>), Skechers (<a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='green'>+3.5%</font>) and Nordstron (<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a> <font color='green'>+1.8%</font>) with Buy ratings.</li> <li>A common factor of the select group of retailers is that valuation looks attractive (14X P/E on average) to UBS&nbsp;and the firm sees potential for consensus EPS estimates to be topped.</li> <li>All four stocks are higher in morning trading, despite in a dip in broad market averages.</li> <li>Sources: MarketWatch, Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365547\" data-linked=\"UBS picks favorite softlines stocks\" data-tweet=\"$AEO $AEO $TPR - UBS picks favorite softlines stocks https://seekingalpha.com/news/3365547-ubs-picks-favorite-softlines-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3365547-ubs-picks-favorite-softlines-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365533\" data-ts=\"1529590203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCS\" target=\"_blank\">SCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365533-steelcase-down-8-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steelcase down 8% post Q1 results</a></h4><ul><li>Steelcase (<a href='https://seekingalpha.com/symbol/SCS' title='Steelcase Inc.'>SCS</a> <font color='red'>-8.7%</font>) reported Q1 revenue of $754M (+2.6% Y/Y). Segment revenue: Americas $535.8M (+0.1% Y/Y), EMEA $137.4M (+21.5% Y/Y) increase was driven by strong project growth in Iberia, UK&nbsp;and Germany, and others $80.8M (-7.1% Y/Y).</li><li>Q1 Overall gross margin&nbsp;<font color='red'>declined by 180 bps</font>&nbsp;to 31.6%. Segment gross margins: Americas&nbsp;<font color='red'>declined by 230 bps</font>&nbsp;to 32.1%, EMEA&nbsp;<font color='green'>improved by 250 bps</font>&nbsp;to 27.7% and Others&nbsp;<font color='red'>declined by 300 bps</font>&nbsp;to 34.2%.</li><li>Q1 Overall operating margin&nbsp;<font color='red'>declined by 168 bps</font>&nbsp;to 3.1%, Segment operating margins: Americas&nbsp;<font color='red'>declined by 250 bps</font>&nbsp;to 5.5%, EMEA&nbsp;<font color='green'>recovered by 640 bps&nbsp;</font>to -1.2% and Others&nbsp;<font color='red'>declined by 890 bps</font>&nbsp;to 2%.</li><li>Orders grew by 5% Y/Y, with Americas +6%, EMEA +7% and Others -6%.</li><li>\"We expect commodity cost increases to continue pressuring our gross margin for another quarter or two while these price adjustments take fuller effect.&nbsp; In addition, our revenue in the&nbsp;Americas&nbsp;over the same period is expected to include a growing mix of project business, including projects won at earlier price levels, which will impact our year-over-year gross margin comparisons&rdquo;, commented Dave Sylvester, Senior VP and CFO.</li><li><strong>2Q19 Outlook</strong>: Revenue $856-890M vs $813.1M consensus; EPS $0.28-0.33 vs $0.28 consensus and Organic growth 6-9%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365344-steelcase-eps-revenue-line\" target=\"_blank\">Steelcase EPS and revenue in-line</a> (June 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365533\" data-linked=\"Steelcase down 8% post Q1 results\" data-tweet=\"$SCS - Steelcase down 8% post Q1 results https://seekingalpha.com/news/3365533-steelcase-down-8-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3365533-steelcase-down-8-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365542\" data-ts=\"1529589864\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365542-reuters-jsw-steel-plans-bid-for-arcelormittals-romanian-plant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: JSW Steel plans bid for ArcelorMittal&#39;s Romanian plant</a></h4><ul>     <li>India&rsquo;s biggest steelmaker JSW Steel <a href=\"https://uk.reuters.com/article/uk-arcelormittal-divestiture-jsw-steel-e/exclusive-jsw-steel-plans-bid-for-arcelormittals-romanian-plant-idUKKBN1JH1XG\" target=\"_blank\">plans to make a bid</a> for ArcelorMittal&rsquo;s (<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='red'>-1.5%</font>) Galati plant in Romania, potentially competing against Ukraine&rsquo;s Metinvest and Italy&rsquo;s Marcegaglia, Reuters reports.</li>     <li>MT has offered six European assets up for sale to get approval from European competition  authorities for its purchase of Italy&rsquo;s giant Ilva plant; Galati, Romania&rsquo;s biggest steel plant, is the largest of the assets.</li><li>Jefferies analysts estimate the combined value of the assets up for sale is $752M-$940M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365542\" data-linked=\"Reuters: JSW Steel plans bid for ArcelorMittal&#39;s Romanian plant\" data-tweet=\"$MT - Reuters: JSW Steel plans bid for ArcelorMittal&#39;s Romanian plant https://seekingalpha.com/news/3365542-reuters-jsw-steel-plans-bid-for-arcelormittals-romanian-plant?source=tweet\" data-url=\"https://seekingalpha.com/news/3365542-reuters-jsw-steel-plans-bid-for-arcelormittals-romanian-plant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365539\" data-ts=\"1529589807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCRX\" target=\"_blank\">PCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365539-herons-gain-is-paciras-pain-down-13-on-herons-positive-htxminus-011-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heron&#39;s gain is Pacira&#39;s pain, down 13% on Heron&#39;s positive HTX-011 data</a></h4><ul><li>Pacira Pharmaceuticals (<a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a> <font color='red'>-13.4%</font>) slumps on average volume as investors react to the potential negative read-through from Heron Therapeutics' successful mid-stage studies of pain med HTX-011, an extended-release formulation of bupivacaine and meloxicam.</li><li>Pacira's EXPAREL (bupivacaine liposomal injectable solution), approved for postsurgical local analgesia and as a nerve block to produce postsurgical regional analgesia, accounted for over 99% of the company's Q1 sales.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365481-heron-pain-med-htxminus-011-successful-mid-stage-studies-shares-23-percent-premarket\" target=\"_blank\">Heron pain med HTX-011 successful in mid-stage studies; shares up 23% premarket</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365539\" data-linked=\"Heron&#39;s gain is Pacira&#39;s pain, down 13% on Heron&#39;s positive HTX-011 data\" data-tweet=\"$PCRX - Heron&#39;s gain is Pacira&#39;s pain, down 13% on Heron&#39;s positive HTX-011 data https://seekingalpha.com/news/3365539-herons-gain-is-paciras-pain-down-13-on-herons-positive-htxminus-011-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3365539-herons-gain-is-paciras-pain-down-13-on-herons-positive-htxminus-011-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365540\" data-ts=\"1529589775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPOT\" target=\"_blank\">SPOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365540-spotifyplus-2-macquarie-sees-25-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spotify +2% as Macquarie sees 25% upside</a></h4><ul>   <li>Spotify (NYSE:<a href='https://seekingalpha.com/symbol/SPOT' title='Spotify'>SPOT</a>) is <font color='green'>up 2%</font> after a start at Outperform by Macquarie, which sees years of growth ahead and a target margin of 30-35% by 2022.</li>    <li>The firm's Amy Yong has given Spotify a Street-high price target of $225; that's exactly 25% upside implied from current pricing of $180.</li>    <li>Spotify is <font color='green'>up 17.4%</font> this month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365540\" data-linked=\"Spotify +2% as Macquarie sees 25% upside\" data-tweet=\"$SPOT - Spotify +2% as Macquarie sees 25% upside https://seekingalpha.com/news/3365540-spotifyplus-2-macquarie-sees-25-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3365540-spotifyplus-2-macquarie-sees-25-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365523\" data-ts=\"1529588722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROV\" target=\"_blank\">TROV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365523-trovagene-on-go-mid-stage-study-of-pcmminus-075-in-mcrpc-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trovagene on go with mid-stage study of PCM-075 in mCRPC; shares up 2%</a></h4><ul><li>Nano cap Trovagene (<a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a> <font color='green'>+1.8%</font>) is up on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17198066-trovagene-announces-start-recruitment-enrollment-phase-2-clinical-trial-pcmminus-075\" target=\"_blank\">announcement </a>that recruitment is underway in its open-label <a href=\"https://clinicaltrials.gov/ct2/show/NCT03414034?lead=trovagene&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> evaluating PCM-075, combined with Johnson &amp; Johnson's ZYTIGA (abiraterone acetate) and prednisone, in patients with metastatic castration-resistant prostate cancer (mCRPC).</li><li>The primary endpoint is the proportion of patients with no PSA progression at week 12. According to ClinicalTrials.gov, the estimated primary completion date is May 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365523\" data-linked=\"Trovagene on go with mid-stage study of PCM-075 in mCRPC; shares up 2%\" data-tweet=\"$TROV - Trovagene on go with mid-stage study of PCM-075 in mCRPC; shares up 2% https://seekingalpha.com/news/3365523-trovagene-on-go-mid-stage-study-of-pcmminus-075-in-mcrpc-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3365523-trovagene-on-go-mid-stage-study-of-pcmminus-075-in-mcrpc-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365521\" data-ts=\"1529587963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365521-inovio-announces-commencement-of-phase-1-2-study-of-triplet-therapy-in-brain-cancer-shares-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio announces commencement of Phase 1/2 study of triplet therapy in brain cancer; shares up 1%</a></h4><ul><li>Inovio Pharmaceuticals (<a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+0.7%</font>) is up out of the gate in response to its <a href=\"https://seekingalpha.com/pr/17198116-inovio-announces-treatment-first-patient-immuno-oncology-study-glioblastoma-gbm-inominus-5401\" target=\"_blank\">announcement </a>that dosing is underway in its open-label <a href=\"https://clinicaltrials.gov/ct2/show/NCT03491683?lead=inovio&amp;phase=014&amp;rank=2\" target=\"_blank\">Phase 1/2 clinical trial</a> evaluating the combination of INO-5401, a T cell-activating immunotherapy, INO-9012, an immune activator encoding IL-12 and Regeneron Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color='red'>-0.2%</font>) REGN2810 (cemiplimab), a PD-1 inhibitor, in patients with newly diagnosed glioblastoma.</li><li>The primary endpoint is safety. Secondary endpoints include overall survival and other efficacy measures.</li><li>According to ClinicalTrials.gov, the estimated completion date is January 2021.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365521\" data-linked=\"Inovio announces commencement of Phase 1/2 study of triplet therapy in brain cancer; shares up 1%\" data-tweet=\"$INO $INO $REGN - Inovio announces commencement of Phase 1/2 study of triplet therapy in brain cancer; shares up 1% https://seekingalpha.com/news/3365521-inovio-announces-commencement-of-phase-1-2-study-of-triplet-therapy-in-brain-cancer-shares-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3365521-inovio-announces-commencement-of-phase-1-2-study-of-triplet-therapy-in-brain-cancer-shares-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365519\" data-ts=\"1529587771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIRI\" target=\"_blank\">SIRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365519-sirius-xmminus-2_8-goldman-trims-to-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sirius XM -2.8% as Goldman trims to Sell</a></h4><ul>   <li>Sirius XM (NASDAQ:<a href='https://seekingalpha.com/symbol/SIRI' title='Sirius XM Holdings Inc.'>SIRI</a>) is <font color='red'>down 2.8%</font> premarket as Goldman cuts to Sell from Neutral.</li>    <li>The firm has a price target of $6, implying 20% downside.</li>    <li>Shares have been on a run YTD, <font color='green'>up 40%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365519\" data-linked=\"Sirius XM -2.8% as Goldman trims to Sell\" data-tweet=\"$SIRI - Sirius XM -2.8% as Goldman trims to Sell https://seekingalpha.com/news/3365519-sirius-xmminus-2_8-goldman-trims-to-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3365519-sirius-xmminus-2_8-goldman-trims-to-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365517\" data-ts=\"1529587684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASCMA\" target=\"_blank\">ASCMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365517-premarket-gainers-of-9-05-06-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (06/21/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/ASCMA' title='Ascent Capital Group, Inc.'>ASCMA</a> <font color='green'>+50%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies Inc.'>SBOT</a> <font color='green'>+47%</font>&nbsp;on bullish <a href=\"https://seekingalpha.com/news/3365489-stellar-bio-45-percent-premarket-bullish-outlook-klh\" target=\"_blank\">outlook</a> for KLH.</li>     <li><a href='https://seekingalpha.com/symbol/CASI' title='CASI Pharmaceuticals'>CASI</a> <font color='green'>+35</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3365480-casi-pharmaceuticals-inks-deal-yiling-wanzhou-entecavir-cilostazol-shares-38-percent\" target=\"_blank\">deal</a> with Yiling Wanzhou for entecavir and cilostazol.</li>     <li><a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a> <font color='green'>+29%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3365481-heron-pain-med-htxminus-011-successful-mid-stage-studies-shares-23-percent-premarket\" target=\"_blank\">successful</a> in mid-stage studies.</li>     <li><a href='https://seekingalpha.com/symbol/VYGR' title='Voyager Therapeutics'>VYGR</a> <font color='green'>+13%</font>&nbsp;as FDA <a href=\"https://seekingalpha.com/news/3365445-fda-grants-rmat-status-voyagers-vy-aadc-gene-therapy-parkinsons\" target=\"_blank\">grants</a> RMAT status for Voyager's VY-AADC gene therapy for Parkinson's.</li>     <li><a href='https://seekingalpha.com/symbol/DRI' title='Darden Restaurants, Inc.'>DRI</a> <font color='green'>+12%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3365427-darden-restaurants-beats-0_04-revenue-line\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a> <font color='green'>+10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3365473-argentina-adrs-move-msci-promotes-emerging-markets-index\" target=\"_blank\">entering</a> into emerging markets index.</li>     <li><a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a> <font color='green'>+9%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3365473-argentina-adrs-move-msci-promotes-emerging-markets-index\" target=\"_blank\">entering</a>&nbsp;into emerging markets index.</li>     <li><a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a> <font color='green'>+9%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3365439-kroger-beats-0_10-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/YTEN' title='Yield10 Bioscience, Inc.'>YTEN</a> <font color='green'>+9%</font>&nbsp;on the <a href=\"https://seekingalpha.com/pr/17198185-yield10-researchers-publish-research-plant-cell-reports-describing-development-camelina\" target=\"_blank\">publication</a> of research describing the development of its Camelina platform as a model crop for novel yield trait discovery.</li>     <li><a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='green'>+8%</font>&nbsp;as <a href=\"https://seekingalpha.com/pr/17198208-avinger-s-ocelot-technology-featured-live-case-transmission-complex-cardiovascular-catheter\" target=\"_blank\">Ocelot image-guided</a> chronic total occlusion crossing device was featured in a live case on June 19<sup>th&nbsp;</sup>at Complex Cardiovascular Catheter Therapeutics.</li>     <li><a href='https://seekingalpha.com/symbol/WEB' title='Web.com Group, Inc'>WEB</a> <font color='green'>+7%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3365496-web-com-agrees-acquired-2b-cash-deal-shares-plus-7_8-percent\" target=\"_blank\">acquired</a> in $2B cash deal.</li>     <li><a href='https://seekingalpha.com/symbol/PDCO' title='Patterson Companies Inc.'>PDCO</a> <font color='green'>+7%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3365425-patterson-eps-line-misses-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17198073-contravir-pharmaceuticals-announces-data-optimized-formulation-txl\" target=\"_blank\">optimized formulation</a> of TXL.</li>     <li><a href='https://seekingalpha.com/symbol/RYTM' title='Rhythm Pharmaceuticals, Inc.'>RYTM</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3365475-rhythm-pharmaceuticals-announces-pricing-public-offering\" target=\"_blank\">announces</a> pricing of public offering.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365517\" data-linked=\"Premarket Gainers as of 9:05 am (06/21/2018)\" data-tweet=\"$ASCMA $SCTY $EDSA - Premarket Gainers as of 9:05 am (06/21/2018) https://seekingalpha.com/news/3365517-premarket-gainers-of-9-05-06-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3365517-premarket-gainers-of-9-05-06-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365515\" data-ts=\"1529587567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LITE\" target=\"_blank\">LITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365515-lumentum-up-infinera-down-goldman-analyst-covers-opticals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lumentum up, Infinera down as Goldman analyst covers opticals</a></h4><ul>   <li>Lumentum (NASDAQ:<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a>) is <font color='green'>up 3.7%</font> premarket as the beneficiary of Goldman analyst Rod Hall's initiation of coverage on optical systems and components.</li>    <li>Lumentum's raised to Buy as Hall notes its rivals continue to struggle with Chinese growth not likely to spike in the short term. Chinese demand should be stable, while growth outside of China should probably continue driven by metro rollouts, he says. (h/t Bloomberg)</li>    <li>He also maintains a Buy rating on Ciena (NASDAQ:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>), but Infinera (NASDAQ:<a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a>) is <font color='red'>down 3.4%</font> as Hall downgrades to Neutral. He's also Neutral on Acacia Communications (<a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a>, <font color='green'>up 2.9%</font> premarket) and Adtran (NASDAQ:<a href='https://seekingalpha.com/symbol/ADTN' title='ADTRAN, Inc.'>ADTN</a>), and upgraded Corning (NYSE:<a href='https://seekingalpha.com/symbol/GLW' title='Corning Inc.'>GLW</a>) to Neutral.</li>    <li>Arris (NASDAQ:<a href='https://seekingalpha.com/symbol/ARRS' title='ARRIS International plc'>ARRS</a>) is <font color='red'>down 2.4%</font> premarket on Goldman's downgrade to Sell. Hall also has a Sell rating on Finisar (NASDAQ:<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a>), <font color='red'>down 0.8%</font> premarket.</li>   <li>Updated 9:35 a.m.: Among other related movers today, <a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a> is up 3.6%; <a href='https://seekingalpha.com/symbol/OCLR' title='Oclaro, Inc.'>OCLR</a> <font color='green'>+1.3%</font>; <a href='https://seekingalpha.com/symbol/MTSI' title='MACOM Technology Solutions Holdings, Inc.'>MTSI</a> <font color='green'>+3.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365515\" data-linked=\"Lumentum up, Infinera down as Goldman analyst covers opticals\" data-tweet=\"$LITE $LITE $CIEN - Lumentum up, Infinera down as Goldman analyst covers opticals https://seekingalpha.com/news/3365515-lumentum-up-infinera-down-goldman-analyst-covers-opticals?source=tweet\" data-url=\"https://seekingalpha.com/news/3365515-lumentum-up-infinera-down-goldman-analyst-covers-opticals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365512\" data-ts=\"1529587385\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONTX\" target=\"_blank\">ONTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365512-onconova-therapeutics-promotes-steven-m-fruchtman-to-role-of-president\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Onconova Therapeutics promotes Steven M. Fruchtman to the role of President</a></h4><ul> <li>Onconova Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a>) <a href=\"https://seekingalpha.com/pr/17198076-onconova-therapeutics-announces-promotion-steven-m-fruchtman-m-d\" target=\"_blank\">announces</a> the promotion of Dr. Steven M. Fruchtman. In his new role as President, Dr. Fruchtman will have oversight over the entire product portfolio, as well as a key role in all other areas of the Company.</li>  <li>Dr. Fruchtman&nbsp;will continue as Chief Medical Officer until a replacement is hired and will report to Dr. Ramesh Kumar, co-founder and CEO of the Company.</li><li>Shares are down&nbsp;<font color='red'>3%</font>&nbsp;premarket.</li>       </ul><div class=\"tiny-share-widget\" data-id=\"3365512\" data-linked=\"Onconova Therapeutics promotes Steven M. Fruchtman to the role of President\" data-tweet=\"$ONTX - Onconova Therapeutics promotes Steven M. Fruchtman to the role of President https://seekingalpha.com/news/3365512-onconova-therapeutics-promotes-steven-m-fruchtman-to-role-of-president?source=tweet\" data-url=\"https://seekingalpha.com/news/3365512-onconova-therapeutics-promotes-steven-m-fruchtman-to-role-of-president\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>102&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365510\" data-ts=\"1529587185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGND\" target=\"_blank\">LGND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365510-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Ligand Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LGND' title='Ligand Pharmaceuticals Incorporated'>LGND</a>) initiated with Buy rating and $260 (31% upside) price target at Argus Research. Shares up a fraction premarket.</li><li>Biofrontera (NASDAQ:<a href='https://seekingalpha.com/symbol/BFRA' title='Biofrontera'>BFRA</a>) initiated with Buy rating and $20 (51% upside) price target at The Benchmark Co.</li><li>Becton, Dickinson and Company (NYSE:<a href='https://seekingalpha.com/symbol/BDX' title='Becton, Dickinson and Company'>BDX</a>) upgraded to Overweight at JPMorgan. Shares down a fraction premarket.</li><li>Glaukos (NYSE:<a href='https://seekingalpha.com/symbol/GKOS' title='Glaukos'>GKOS</a>) downgraded to Neutral at JPMorgan. Shares down&nbsp;<font color='red'>5%&nbsp;</font>premarket.</li><li>NuVasive (NASDAQ:<a href='https://seekingalpha.com/symbol/NUVA' title='NuVasive, Inc.'>NUVA</a>) downgraded to Neutral at JPMorgan.</li><li>Ultragenyx Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a>) downgraded to Neutral at Credit Suisse.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365510\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$LGND $LGND $BFRA - Premarket analyst action - healthcare https://seekingalpha.com/news/3365510-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3365510-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365507\" data-ts=\"1529587057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTE\" target=\"_blank\">PTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365507-polarityte-appoints-paul-mann-chief-financial-officer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Polarityte appoints Paul Mann as Chief Financial Officer</a></h4><ul><li>PolarityTE (COOL) <a href=\"https://seekingalpha.com/pr/17198223-update-polarityte-appoints-paul-mann-highbridge-capital-chief-financial-officer\" target=\"_blank\">announces</a>&nbsp;Paul Mann as the new Chief Financial Officer of the Company. Most recently, Mr. Mann served as the Healthcare Portfolio Manager at Highbridge Capital Management.</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3365507\" data-linked=\"Polarityte appoints Paul Mann as Chief Financial Officer\" data-tweet=\"$PTE - Polarityte appoints Paul Mann as Chief Financial Officer https://seekingalpha.com/news/3365507-polarityte-appoints-paul-mann-chief-financial-officer?source=tweet\" data-url=\"https://seekingalpha.com/news/3365507-polarityte-appoints-paul-mann-chief-financial-officer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365506\" data-ts=\"1529587006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365506-intelplus-2_1-on-ceo-resignation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel +2.1% on CEO resignation</a></h4><ul><li>        Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) CEO Brian Krzanich <a href=\"https://seekingalpha.com/pr/17198352-intel-ceo-brian-krzanich-resigns-board-appoints-bob-swan-interim-ceo\" target=\"_blank\">resigns</a> due to violating the company&rsquo;s non-fraternization policy with a consensual relationship with an employee.</li><li>               CFO Robert Swan will become interim CEO effective immediately.&nbsp;</li><li>               Intel shares are&nbsp;<font color='green'>up 2.1%</font>&nbsp;premarket to $54.56.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3365506\" data-linked=\"Intel +2.1% on CEO resignation\" data-tweet=\"$INTC - Intel +2.1% on CEO resignation https://seekingalpha.com/news/3365506-intelplus-2_1-on-ceo-resignation?source=tweet\" data-url=\"https://seekingalpha.com/news/3365506-intelplus-2_1-on-ceo-resignation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>115&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365503\" data-ts=\"1529586842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVIV\" target=\"_blank\">NVIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365503-premarket-losers-of-9-05-6-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (6/21/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a>&nbsp;<font color='red'>-42%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3365435-invivo-continues-stock-offering-stoked-selloff-26-percent-premarket\" target=\"_blank\">after</a> stock sell-off.</li><li><a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a>&nbsp;<font color='red'>-15%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3365358-veritone-minus-5_1-percent-proposed-share-offering\" target=\"_blank\">announcing</a> public share offering.</li><li><a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a>&nbsp;<font color='red'>-15%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3365493-moleculin-announces-2_3m-registered-direct-offering-shares-15-percent-premarket\" target=\"_blank\">announcing</a> $2.3M registered direct offering.</li><li><a href='https://seekingalpha.com/symbol/LMNR' title='Limoneira'>LMNR</a>&nbsp;<font color='red'>-14%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3365381-limoneira-lower-50m-public-share-offering\" target=\"_blank\">announcement</a> of a $50M&nbsp;public stock offering.</li><li><a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='red'>-13%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17198064-gevo-avfuel-enter-renewable-jet-fuel-supply-agreement\" target=\"_blank\">entering</a> into renewable jet fuel supply agreement with Avfuel.</li><li><a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3365333-american-outdoor-brands-beats-0_14-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a>&nbsp;<font color='red'>-7%</font>&nbsp;as Posco <a href=\"https://seekingalpha.com/news/3365380-fuelcell-energy-minus-1_8-percent-posco-terminates-mou\" target=\"_blank\">terminates</a> MOU.</li><li><a href='https://seekingalpha.com/symbol/CLPS' title='CLPS, Inc'>CLPS</a> <font color='red'>-4%</font>.</li><li><a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365503\" data-linked=\"Premarket Losers as of 9:05 am (6/21/2018)\" data-tweet=\"$NVIV $NVIV $VERI - Premarket Losers as of 9:05 am (6/21/2018) https://seekingalpha.com/news/3365503-premarket-losers-of-9-05-6-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3365503-premarket-losers-of-9-05-6-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365501\" data-ts=\"1529586638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRIL\" target=\"_blank\">TRIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365501-trillium-up-13-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trillium up 13% premarket</a></h4><ul><li>Thinly traded nano cap Trillium Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TRIL' title='Trillium Therapeutics Inc.'>TRIL</a>) is up&nbsp;<font color='green'>13%</font>&nbsp;premarket on light volume, potentially poised to add to yesterday's&nbsp;<font color='green'>5%</font>&nbsp;gain.</li><li>The action has perked up lately in anti-CD47 players. Trillium's candidate is TTI-622, a fusion protein that has Orphan Drug status in the U.S. for cutaneous T-cell lymphoma.</li><li>Recent IPO Surface Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/SURF' title='Surface Oncology'>SURF</a>) broke through resistance three days ago. Its lead candidate is CD47-targeting SRF231.</li><li>TG Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TGTX' title='TG Therapeutics, Inc.'>TGTX</a>), up almost&nbsp;<font color='green'>11%&nbsp;</font>since touching $13.20 on June 15, is co-developing a bispecific antibody with Novimmune SA that targets CD47 and CD19 for the treatment of B-cell blood cancers.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365136-tg-therapeutics-teams-novimmune-develop-bispecific-antibody-blood-cancers-shares-1-percent\" target=\"_blank\">TG Therapeutics teams up with Novimmune to develop bispecific antibody for blood cancers; shares up 1% premarket</a> (June 20)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363855-early-stage-study-commences-trilliums-blood-cancer-candidate-ttiminus-622\" target=\"_blank\">Early-stage study commences for Trillium's blood cancer candidate TTI-622</a> (June 14)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3341392-surface-oncology-deck-ipo\" target=\"_blank\">Surface Oncology on deck for IPO</a> (March 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365501\" data-linked=\"Trillium up 13% premarket\" data-tweet=\"$TRIL $TRIL $SURF - Trillium up 13% premarket https://seekingalpha.com/news/3365501-trillium-up-13-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3365501-trillium-up-13-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365497\" data-ts=\"1529586191\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARAY\" target=\"_blank\">ARAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365497-accuray-receives-aerb-approval-for-sale-and-supply-of-radixact-x9-system-in-india\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Accuray receives AERB approval for sale and supply of Radixact X9 system in India</a></h4><ul> <li>Accuray Incorporated (NASDAQ:<a href='https://seekingalpha.com/symbol/ARAY' title='Accuray Incorporated'>ARAY</a>) has <a href=\"https://seekingalpha.com/pr/17198031-accuray-receives-aerb-approval-sale-supply-radixact-x9-system-india\" target=\"_blank\">received</a> an Atomic Energy Regulatory Board &#40;AERB&#41; Type Approval for its <a href=\"https://www.accuray.com/radixact/\" target=\"_blank\">Radixact</a>&nbsp;X9 System in India.</li><li>The AERB Type Approval indicates the device conforms to established safety standards and will enable Accuray to sell, and Indian hospitals to import,&nbsp;<a href=\"https://www.accuray.com/tomotherapy/\" target=\"_blank\">TomoTherapy</a>&nbsp;platform.</li>                  <li>The Radixact System is fully integrated with the Accuray Precision&nbsp;Treatment Planning System and iDMS Data Management System.</li><li>Shares are up&nbsp;<font color='green'>10%</font>&nbsp;premarket.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3365497\" data-linked=\"Accuray receives AERB approval for sale and supply of Radixact X9 system in India\" data-tweet=\"$ARAY - Accuray receives AERB approval for sale and supply of Radixact X9 system in India https://seekingalpha.com/news/3365497-accuray-receives-aerb-approval-for-sale-and-supply-of-radixact-x9-system-in-india?source=tweet\" data-url=\"https://seekingalpha.com/news/3365497-accuray-receives-aerb-approval-for-sale-and-supply-of-radixact-x9-system-in-india\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365496\" data-ts=\"1529586054\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WEB\" target=\"_blank\">WEB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365496-web-com-agrees-to-be-acquired-in-2b-cash-deal-sharesplus-7_8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Web.com agrees to be acquired in $2B cash deal; shares +7.8%</a></h4><ul><li>        Web.com (NASDAQ:<a href='https://seekingalpha.com/symbol/WEB' title='Web.com Group, Inc'>WEB</a>) <a href=\"https://seekingalpha.com/pr/17198232-web-com-announces-agreement-acquired-affiliate-siris-capital-group-llc-25_00-per-share-cash\" target=\"_blank\">agrees</a> to be acquired by a Siris Capital Group affiliate for $25/share in cash.</li><li>               The deal is valued at approximately $2B and is expected to close in Q4.&nbsp;</li><li>               Web.com shares are&nbsp;<font color='green'>up 7.8%</font>&nbsp;premarket to $25.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3365496\" data-linked=\"Web.com agrees to be acquired in $2B cash deal; shares +7.8%\" data-tweet=\"$WEB - Web.com agrees to be acquired in $2B cash deal; shares +7.8% https://seekingalpha.com/news/3365496-web-com-agrees-to-be-acquired-in-2b-cash-deal-sharesplus-7_8?source=tweet\" data-url=\"https://seekingalpha.com/news/3365496-web-com-agrees-to-be-acquired-in-2b-cash-deal-sharesplus-7_8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365493\" data-ts=\"1529585802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBRX\" target=\"_blank\">MBRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365493-moleculin-announces-2_3m-registered-direct-offering-shares-down-15-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moleculin announces $2.3M registered direct offering; shares down 15% premarket</a></h4><ul> <li>Moleculin Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a>) has <a href=\"https://seekingalpha.com/pr/17198022-moleculin-announces-2_3-million-registered-direct-offering-priced-market\" target=\"_blank\">entered</a> into a definitive agreement with institutional investors for a registered direct offering of securities with gross proceeds of ~$2.3M.</li>   <li>The Company will issue 1,092,636 shares of common stock at a purchase price of $2.105 per share. The Company will also issue warrants to purchase 0.65 of a share of common stock at an exercise price of $2.02 per share.The warrants will expire five years from the initial exercise date.</li>    <li>Net proceeds will be used for its clinical trials, preclinical programs, for R&amp;D activities and for general corporate purposes.</li><li>Closing date is June 22.</li><li>Shares are down&nbsp;<font color='red'>15%</font>&nbsp;premarket.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3365493\" data-linked=\"Moleculin announces $2.3M registered direct offering; shares down 15% premarket\" data-tweet=\"$MBRX - Moleculin announces $2.3M registered direct offering; shares down 15% premarket https://seekingalpha.com/news/3365493-moleculin-announces-2_3m-registered-direct-offering-shares-down-15-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3365493-moleculin-announces-2_3m-registered-direct-offering-shares-down-15-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365491\" data-ts=\"1529585687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365491-barnes-noble-down-8_5-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp; Noble down 8.5% post Q4 results</a></h4><ul><li>Barnes &amp; Noble (NYSE:<a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble Inc'>BKS</a>)&nbsp;reports comparable&nbsp;store sales declined 4.1% in <a href=\"https://seekingalpha.com/pr/17198198-barnes-and-noble-reports-fiscal-2018-year-end-financial-results\" target=\"_blank\">Q4</a>.</li><li>Retail sales dropped 3.9% to $765.45M.</li><li>NOOK sales fell 21.6% to $25.09M.</li><li>Gross margin rate down 40 bps to 29.1%.</li><li>SG&amp;A expense rate +30 bps to 29.3%.</li><li>Merchandise inventories up 1.2% $958.2M.</li><li>The company expects FY2019 EBITDA to be in the range of $175M to $200M.</li><li>BKS&nbsp;<font color='red'>-8.53%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365484-barnes-and-noble-misses-0_09-beats-revenue\" target=\"_blank\">Barnes &amp; Noble misses by $0.09, beats on revenue</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365491\" data-linked=\"Barnes &amp; Noble down 8.5% post Q4 results\" data-tweet=\"$BKS - Barnes &amp; Noble down 8.5% post Q4 results https://seekingalpha.com/news/3365491-barnes-noble-down-8_5-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3365491-barnes-noble-down-8_5-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365489\" data-ts=\"1529585501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBOT\" target=\"_blank\">SBOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365489-stellar-bio-up-45-premarket-bullish-outlook-for-klh\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stellar Bio up 45% premarket bullish outlook for KLH</a></h4><ul><li>Nano cap Stellar Biotechnologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies Inc.'>SBOT</a>) is up&nbsp;<font color='green'>45%&nbsp;</font>premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/17198025-stellar-reports-positive-research-results-klh-glycosylation-study\" target=\"_blank\">announcement </a>of positive results from a research study that confirmed the batch consistency of KLH, used as a carrier molecule and immunostimulant in clinical trials of drug candidates.</li><li>The company says <a href=\"https://www.stellarbiotechnologies.com/about-stellar/overview\" target=\"_blank\">KLH</a>, purified from hemocyanin protein from an ocean-dwelling mollusc called the Keyhole Limpet, has demonstrated an ability to produce vigorous primary and secondary immune responses.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365489\" data-linked=\"Stellar Bio up 45% premarket bullish outlook for KLH\" data-tweet=\"$SBOT $EDSA - Stellar Bio up 45% premarket bullish outlook for KLH https://seekingalpha.com/news/3365489-stellar-bio-up-45-premarket-bullish-outlook-for-klh?source=tweet\" data-url=\"https://seekingalpha.com/news/3365489-stellar-bio-up-45-premarket-bullish-outlook-for-klh\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365481\" data-ts=\"1529584267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRTX\" target=\"_blank\">HRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365481-heron-pain-med-htxminus-011-successful-in-mid-stage-studies-shares-up-23-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heron pain med HTX-011 successful in mid-stage studies; shares up 23% premarket</a></h4><ul><li>Heron Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a>) is up&nbsp;<font color='green'>23%</font>&nbsp;premarket on the heels of its <a href=\"https://seekingalpha.com/pr/17198069-heron-announces-positive-topline-results-phase-2b-clinical-studies-htxminus-011-total-knee\" target=\"_blank\">announcement </a>of positive results from two Phase 2b clinical trials evaluating local anesthetic HTX-011.</li><li>The first, Study 209, showed administration with HTX-011 alone in patients undergoing total knee arthroplasty (knee replacement) reduced pain intensity 19% versus placebo (p=0.0002). When administered with ropivacaine or bupivacaine, pain intensity was reduced 23% compared to placebo (p&lt;0.0001), significantly better that ropivacaine or bupivacaine alone. The HTX-011 combination approach significantly reduced opioid use through 48 and 72 hours post surgery.</li><li>The second, Study 211, evaluated the pain-reducing effect of HTX-011 in patients undergoing breast augmentation when administered into the surgical site or via lateral or medial pectoral nerve block before surgery. Treatment with HTX-011, administered either way, showed a statistically significant 22% reduction in pain intensity compared to placebo (p=0.0023 and p=0.0055, respectively). The pain reduction from HTX-011 was ~3x that of bupivacaine administered as a nerve block.</li><li><a href=\"http://www.herontx.com/HTX-011\" target=\"_blank\">HTX-011</a>&nbsp;is an injectable formulation based on the company's&nbsp;<a href=\"http://www.herontx.com/our-technologies\" target=\"_blank\">Bichronomer&nbsp;polymer-based drug delivery platform</a>&nbsp;which enables the release of bupivacaine and meloxicam over an extended period. It has <a href=\"https://seekingalpha.com/pr/17198158-htxminus-011-postoperative-pain-management-receives-breakthrough-therapy-designation-fda\" target=\"_blank\">Breakthrough Therapy status</a> for the management of postoperative pain.</li><li>The company will host a conference call momentarily to discuss the data.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365481\" data-linked=\"Heron pain med HTX-011 successful in mid-stage studies; shares up 23% premarket\" data-tweet=\"$HRTX - Heron pain med HTX-011 successful in mid-stage studies; shares up 23% premarket https://seekingalpha.com/news/3365481-heron-pain-med-htxminus-011-successful-in-mid-stage-studies-shares-up-23-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3365481-heron-pain-med-htxminus-011-successful-in-mid-stage-studies-shares-up-23-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365480\" data-ts=\"1529584141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASI\" target=\"_blank\">CASI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365480-casi-pharmaceuticals-inks-deal-yiling-wanzhou-for-entecavir-and-cilostazol-shares-are-up-38\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CASI Pharmaceuticals inks deal with Yiling Wanzhou for entecavir and cilostazol; shares are up 38% premarket</a></h4><ul><li>CASI Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CASI' title='CASI Pharmaceuticals'>CASI</a>)&nbsp;<a href=\"https://seekingalpha.com/pr/17197995-casi-pharmaceuticals-enters-strategic-partnering-contract-manufacturing-agreement-yiling\" target=\"_blank\">announces</a> a strategic and long-term manufacturing agreement with Yiling Wanzhou International Pharmaceutical Co., for the manufacturing of entecavir and cilostazol.</li><li>The contracted manufacturing facilities will enable CASI to sell both entecavir and cilostazol in the U.S., China and worldwide markets.</li><li>Financial terms are not disclosed.</li><li>CASI share are up&nbsp;<font color='green'>38%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365480\" data-linked=\"CASI Pharmaceuticals inks deal with Yiling Wanzhou for entecavir and cilostazol; shares are up 38% premarket\" data-tweet=\"$CASI - CASI Pharmaceuticals inks deal with Yiling Wanzhou for entecavir and cilostazol; shares are up 38% premarket https://seekingalpha.com/news/3365480-casi-pharmaceuticals-inks-deal-yiling-wanzhou-for-entecavir-and-cilostazol-shares-are-up-38?source=tweet\" data-url=\"https://seekingalpha.com/news/3365480-casi-pharmaceuticals-inks-deal-yiling-wanzhou-for-entecavir-and-cilostazol-shares-are-up-38\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365475\" data-ts=\"1529583625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RYTM\" target=\"_blank\">RYTM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365475-rhythm-pharmaceuticals-announces-pricing-of-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rhythm Pharmaceuticals announces pricing of public offering</a></h4><ul> <li>Rhythm Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RYTM' title='Rhythm Pharmaceuticals, Inc.'>RYTM</a>) <a href=\"https://seekingalpha.com/pr/17197831-rhythm-pharmaceuticals-inc-announces-pricing-public-offering\" target=\"_blank\">prices</a> its public offering of 5,732,000 shares of common stock at a price of $26.42 per share.</li><li>Underwriters over-allotment is an&nbsp;additional&nbsp;859,800&nbsp;shares. Closing date is June 25.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3365475\" data-linked=\"Rhythm Pharmaceuticals announces pricing of public offering\" data-tweet=\"$RYTM - Rhythm Pharmaceuticals announces pricing of public offering https://seekingalpha.com/news/3365475-rhythm-pharmaceuticals-announces-pricing-of-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3365475-rhythm-pharmaceuticals-announces-pricing-of-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365474\" data-ts=\"1529583558\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNT\" target=\"_blank\">SYNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365474-syntelminus-3_1-on-downgrade-15-downside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Syntel -3.1% on downgrade with 15% downside</a></h4><ul><li>        Wells Fargo <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Wells+Fargo+Downgrades+Syntel%2C+Inc.+%28SYNT%29+to+Underperform+Citing+Valuation+Following+Strong+Equity+Appreciation/14328567.html\" target=\"_blank\">downgrades</a> Syntel (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNT' title='Syntel, Inc.'>SYNT</a>) from Market Perform to Underperform and raises the price target from $26 to $29.</li><li>                  New target represents a 15% downside to yesterday&rsquo;s close.    </li><li>               Syntel shares are&nbsp;<font color='red'>down 3.1%</font>&nbsp;premarket to $33.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3365474\" data-linked=\"Syntel -3.1% on downgrade with 15% downside\" data-tweet=\"$SYNT - Syntel -3.1% on downgrade with 15% downside https://seekingalpha.com/news/3365474-syntelminus-3_1-on-downgrade-15-downside?source=tweet\" data-url=\"https://seekingalpha.com/news/3365474-syntelminus-3_1-on-downgrade-15-downside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365473\" data-ts=\"1529583522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGS\" target=\"_blank\">TGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365473-argentina-adrs-on-move-msci-promotes-to-emerging-markets-index\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Argentina ADRs on the move as MSCI promotes to Emerging Markets Index</a></h4><ul>     <li>Argentina-exposed ADR surge following the <a href=\"https://seekingalpha.com/news/3365367-argentine-adrs-get-boost-msci-reclassifies-argentina-emerging-markets\" target=\"_blank\">MSCI's reclassification</a> of its Argentina index to Emerging Markets status from Frontier Markets.</li>     <li>International institutional investors expressed confidence in Argentina&rsquo;s ability to maintain current equity market accessibility conditions, MSCI says.</li>     <li>In premarket trade: <a href='https://seekingalpha.com/symbol/TGS' title='Transportadora de Gas del Sur'>TGS</a> <font color='green'>+20.6%</font>, <a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco Francs S.A.  ADR'>BFR</a> <font color='green'>+12.6%</font>, <a href='https://seekingalpha.com/symbol/EDN' title='Empresa Distribuidora y Comercializadora Norte S.A.'>EDN</a> <font color='green'>+11.6%</font>, <a href='https://seekingalpha.com/symbol/LOMA' title='Loma Negra Compania Industrial Argentina Sociedad  ADS'>LOMA</a> <font color='green'>+11.3%</font>, <a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a> <font color='green'>+11.1%</font>, <a href='https://seekingalpha.com/symbol/TEO' title='Telecom Argentina S.A.'>TEO</a> <font color='green'>+10.6%</font>, <a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a> <font color='green'>+9.4%</font>,  <a href='https://seekingalpha.com/symbol/ARGT' title='Global X MSCI Argentina ETF'>ARGT</a> <font color='green'>+8.8%</font>, <a href='https://seekingalpha.com/symbol/PAM' title='Pampa Energia S.A.'>PAM</a> <font color='green'>+7.7%</font>, <a href='https://seekingalpha.com/symbol/YPF' title='YPF Sociedad Anonima'>YPF</a> <font color='green'>+6.6%</font>, <a href='https://seekingalpha.com/symbol/IRS' title='IRSA Inversiones Y Representaciones S.A.'>IRS</a> <font color='green'>+4.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365473\" data-linked=\"Argentina ADRs on the move as MSCI promotes to Emerging Markets Index\" data-tweet=\"$TGS $TGS $BBAR - Argentina ADRs on the move as MSCI promotes to Emerging Markets Index https://seekingalpha.com/news/3365473-argentina-adrs-on-move-msci-promotes-to-emerging-markets-index?source=tweet\" data-url=\"https://seekingalpha.com/news/3365473-argentina-adrs-on-move-msci-promotes-to-emerging-markets-index\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}